<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Il paziente nascosto: un corso sulla meta-analisi dei dati dei singoli partecipanti</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,400;0,600;0,700;1,400;1,600&amp;family=Source+Sans+Pro:wght@300;400;600;700&amp;display=swap" rel="stylesheet"/>
<style>
    /* Fallback fonts for offline use */
    @font-face {
      font-family: 'Cormorant Garamond';
      src: local('Cormorant Garamond'), local('Georgia'), local('Times New Roman');
      font-display: swap;
    }
    @font-face {
      font-family: 'Source Sans Pro';
      src: local('Source Sans Pro'), local('Segoe UI'), local('Arial');
      font-display: swap;
    }

    :root {
      --navy: #1E2761;
      --deep-navy: #141B3D;
      --gold: #D4AF37;
      --cream: #FAF8F5;
      --light-cream: #FFFFFF;
      --text: #2D3748;
      --light-text: #718096;
      --red: #C53030;
      --green: #22c55e;
      --teal: #00D4AA;
      --purple: #A855F7;
      --orange: #F97316;
      --blue: #3B82F6;
      --blood-red: #8B0000;
      --transition: 0.5s cubic-bezier(0.4, 0, 0.2, 1);
    }

    * { margin: 0; padding: 0; box-sizing: border-box; }

    /* Accessibility: Skip link */
    .skip-link {
      position: absolute;
      top: -40px;
      left: 0;
      background: var(--gold);
      color: var(--navy);
      padding: 8px 16px;
      z-index: 1000;
      font-weight: 600;
      text-decoration: none;
      border-radius: 0 0 4px 0;
    }
    .skip-link:focus {
      top: 0;
    }

    /* Accessibility: Focus indicators */
    *:focus {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
    }
    *:focus:not(:focus-visible) {
      outline: none;
    }
    *:focus-visible {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
    }

    /* Accessibility: Reduced motion */
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
      .slide { transition: none; }
    }

    /* Accessibility: Screen reader only */
    .sr-only {
      position: absolute;
      width: 1px;
      height: 1px;
      padding: 0;
      margin: -1px;
      overflow: hidden;
      clip: rect(0, 0, 0, 0);
      white-space: nowrap;
      border: 0;
    }

    /* Accessibility: Live region for announcements */
    .aria-live-region {
      position: absolute;
      width: 1px;
      height: 1px;
      padding: 0;
      margin: -1px;
      overflow: hidden;
      clip: rect(0, 0, 0, 0);
      white-space: nowrap;
      border: 0;
    }

    html, body {
      height: 100%;
      font-family: 'Source Sans Pro', 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
      background: var(--deep-navy);
      color: var(--cream);
    }

    .course-container {
      display: flex;
      height: 100vh;
      overflow: hidden;
    }

    /* Sidebar */
    .sidebar {
      width: 300px;
      background: linear-gradient(180deg, var(--deep-navy) 0%, #0a0f1a 100%);
      border-right: 1px solid rgba(212,175,55,0.2);
      display: flex;
      flex-direction: column;
      flex-shrink: 0;
    }

    /* mobile sidebar handled by hamburger toggle below */

    .sidebar-header {
      padding: 1.5rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
    }

    .sidebar-header h1 {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.4rem;
      font-weight: 700;
      color: var(--gold);
      margin-bottom: 0.25rem;
    }

    .sidebar-header p {
      font-size: 0.8rem;
      color: rgba(255,255,255,0.6);
    }

    .module-list {
      flex: 1;
      overflow-y: auto;
      padding: 1rem 0;
    }

    .module-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.75rem 1.5rem;
      cursor: pointer;
      transition: all 0.2s;
      border-left: 3px solid transparent;
    }

    .module-item:hover { background: rgba(212,175,55,0.1); }
    .module-item.active { background: rgba(212,175,55,0.15); border-left-color: var(--gold); }
    .module-item.completed .module-number { background: var(--green); color: white; }

    .module-number {
      width: 28px;
      height: 28px;
      border-radius: 50%;
      background: rgba(255,255,255,0.1);
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.75rem;
      font-weight: 700;
      flex-shrink: 0;
    }

    .module-item.active .module-number { background: var(--gold); color: var(--navy); }

    .module-info { flex: 1; min-width: 0; }
    .module-title { font-size: 0.85rem; font-weight: 600; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; }
    .module-subtitle { font-size: 0.7rem; color: rgba(255,255,255,0.7); }

    .sidebar-footer {
      padding: 1rem 1.5rem;
      border-top: 1px solid rgba(212,175,55,0.2);
      font-size: 0.7rem;
      color: rgba(255,255,255,0.4);
      line-height: 1.4;
    }

    /* Main Content */
    .main-content {
      flex: 1;
      display: flex;
      flex-direction: column;
      overflow: hidden;
    }

    .content-header {
      padding: 1rem 2rem;
      background: rgba(0,0,0,0.3);
      border-bottom: 1px solid rgba(212,175,55,0.2);
      display: flex;
      align-items: center;
      justify-content: space-between;
    }

    .breadcrumb { font-size: 0.85rem; color: rgba(255,255,255,0.6); }
    .breadcrumb span { color: var(--gold); }

    .header-actions { display: flex; gap: 0.5rem; }

    .btn {
      padding: 0.5rem 1rem;
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 6px;
      background: rgba(255,255,255,0.05);
      color: var(--cream);
      font-size: 0.8rem;
      cursor: pointer;
      transition: all 0.2s;
    }

    .btn:hover { background: rgba(212,175,55,0.2); border-color: var(--gold); }
    .btn:focus-visible { box-shadow: 0 0 0 3px rgba(212,175,55,0.5); }
    .btn.primary { background: var(--gold); color: var(--navy); border-color: var(--gold); font-weight: 600; }
    .btn.primary:focus-visible { box-shadow: 0 0 0 3px rgba(212,175,55,0.7); }

    .content-body { flex: 1; overflow: hidden; display: flex; }

    /* Slides */
    .slides-container { flex: 1; position: relative; overflow: hidden; }

    .module-slides { display: none; width: 100%; height: 100%; }
    .module-slides.active { display: block; }

    .slide {
      position: absolute;
      top: 0; left: 0;
      width: 100%; height: 100%;
      display: flex;
      flex-direction: column;
      justify-content: flex-start;
      align-items: center;
      padding: 2rem 2rem 4rem 2rem;
      padding-top: 3rem;
      opacity: 0;
      visibility: hidden;
      transition: opacity var(--transition), visibility var(--transition);
      overflow-y: auto;
      overflow-x: hidden;
    }

    .slide .content { margin-top: auto; margin-bottom: auto; }
    .slide > * { max-width: 100%; word-wrap: break-word; }
    .slide.active { opacity: 1; visibility: visible; }

    .slide.dark { background: var(--deep-navy); color: var(--cream); }
    .slide.light { background: var(--cream); color: var(--text); }
    .slide.black { background: #000; color: var(--cream); }
    .slide.gradient { background: linear-gradient(135deg, var(--deep-navy) 0%, #2a1a4a 100%); color: var(--cream); }
    .slide.blood { background: linear-gradient(135deg, #1a0a0a 0%, #2d1515 100%); color: var(--cream); }
    .slide.hope { background: linear-gradient(135deg, #0a1a0a 0%, #152d15 100%); color: var(--cream); }
    .slide.ipd { background: linear-gradient(135deg, #0a1a2d 0%, #152d3d 100%); color: var(--cream); }
    .slide.precision { background: linear-gradient(135deg, #1a0a2d 0%, #2d153d 100%); color: var(--cream); }

    /* Typography */
    .serif { font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif; }

    .title {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: clamp(1.8rem, 5vw, 3.5rem);
      font-weight: 700;
      margin-bottom: 1rem;
      line-height: 1.2;
    }

    .title.navy { color: var(--navy); }
    .title.gold { color: var(--gold); }
    .title.cream { color: var(--cream); }
    .title.red { color: var(--red); }
    .title.green { color: var(--green); }
    .title.blue { color: var(--blue); }
    .title.purple { color: var(--purple); }

    .subtitle {
      font-size: clamp(1rem, 2vw, 1.5rem);
      color: var(--light-text);
      margin-bottom: 2rem;
    }

    .slide.dark .subtitle { color: rgba(255,255,255,0.7); }

    .big-number {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: clamp(4rem, 15vw, 10rem);
      font-weight: 700;
      line-height: 1;
    }

    .big-number.navy { color: var(--navy); }
    .big-number.gold { color: var(--gold); }
    .big-number.red { color: var(--red); }
    .big-number.green { color: var(--green); }
    .big-number.blue { color: var(--blue); }

    /* Refrain */
    .refrain {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: clamp(1.4rem, 4vw, 2.5rem);
      font-style: italic;
      color: var(--gold);
      text-align: center;
      max-width: 800px;
      line-height: 1.4;
    }

    .refrain.warning {
      color: var(--red);
      border-left: 4px solid var(--red);
      padding-left: 1.5rem;
      text-align: left;
    }

    .refrain.hope { color: var(--green); }
    .refrain.insight { color: var(--blue); }

    /* Rhetorical */
    .rhetorical {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: clamp(1.2rem, 3vw, 2rem);
      color: rgba(255,255,255,0.9);
      text-align: center;
      max-width: 700px;
      line-height: 1.5;
    }

    .rhetorical em { color: var(--gold); font-style: normal; }

    /* Simple explanation box */
    .simple-box {
      background: linear-gradient(135deg, rgba(0,212,170,0.1), rgba(0,0,0,0.2));
      border: 2px solid var(--teal);
      border-radius: 12px;
      padding: 1.5rem;
      max-width: 600px;
      margin: 1rem 0;
    }

    .simple-box.blue {
      background: linear-gradient(135deg, rgba(59,130,246,0.1), rgba(0,0,0,0.2));
      border-color: var(--blue);
    }

    .simple-box.purple {
      background: linear-gradient(135deg, rgba(168,85,247,0.1), rgba(0,0,0,0.2));
      border-color: var(--purple);
    }

    .simple-box .simple-title {
      color: var(--teal);
      font-size: 0.75rem;
      font-weight: 700;
      letter-spacing: 0.1em;
      margin-bottom: 0.75rem;
    }

    .simple-box.blue .simple-title { color: var(--blue); }
    .simple-box.purple .simple-title { color: var(--purple); }

    .simple-box .simple-text {
      font-size: 1.1rem;
      line-height: 1.6;
    }

    .simple-box .simple-text strong { color: var(--gold); }

    /* Story card */
    .story-card {
      background: rgba(0,0,0,0.3);
      border-left: 4px solid var(--gold);
      padding: 1.5rem 2rem;
      max-width: 700px;
      margin: 1rem 0;
    }

    .story-card .place {
      font-size: 0.75rem;
      color: var(--gold);
      letter-spacing: 0.1em;
      margin-bottom: 0.5rem;
    }

    .story-card .narrative {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.1rem;
      line-height: 1.6;
      color: rgba(255,255,255,0.9);
    }

    .story-card .source {
      font-size: 0.7rem;
      color: rgba(255,255,255,0.5);
      margin-top: 1rem;
      font-style: italic;
    }

    /* Decision Tree */
    .decision-tree {
      background: rgba(0,0,0,0.3);
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 1.5rem;
      max-width: 800px;
      width: 100%;
    }

    .decision-tree h4 {
      color: var(--gold);
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.1rem;
      margin-bottom: 1rem;
      text-align: center;
    }

    .tree-level {
      display: flex;
      justify-content: center;
      gap: 0.5rem;
      margin: 0.5rem 0;
      position: relative;
      flex-wrap: wrap;
    }

    .tree-node {
      background: var(--navy);
      border: 2px solid var(--gold);
      border-radius: 8px;
      padding: 0.75rem 1rem;
      text-align: center;
      min-width: 120px;
      font-size: 0.8rem;
    }

    .tree-node.root { background: var(--gold); color: var(--navy); font-weight: 700; }
    .tree-node.question { background: rgba(168,85,247,0.3); border-color: var(--purple); }
    .tree-node.yes { background: rgba(34,197,94,0.3); border-color: var(--green); }
    .tree-node.no { background: rgba(197,48,48,0.3); border-color: var(--red); }
    .tree-node.ipd { background: rgba(59,130,246,0.3); border-color: var(--blue); }
    .tree-node.aggregate { background: rgba(249,115,22,0.3); border-color: var(--orange); }
    .tree-node.action { background: var(--teal); color: var(--navy); font-weight: 600; }

    .tree-arrow {
      color: var(--gold);
      font-size: 1.5rem;
      text-align: center;
    }

    .tree-label {
      font-size: 0.7rem;
      color: rgba(255,255,255,0.7);
      text-align: center;
      margin-top: 0.25rem;
    }

    /* Comparison boxes */
    .compare-grid {
      display: grid;
      grid-template-columns: repeat(2, 1fr);
      gap: 1rem;
      max-width: 800px;
      width: 100%;
    }

    @media (max-width: 600px) { .compare-grid { grid-template-columns: 1fr; } }

    .compare-box {
      background: rgba(0,0,0,0.3);
      border-radius: 12px;
      padding: 1.5rem;
      border: 2px solid;
    }

    .compare-box.aggregate { border-color: var(--orange); }
    .compare-box.ipd { border-color: var(--blue); }

    .compare-box h4 {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.1rem;
      margin-bottom: 0.75rem;
    }

    .compare-box.aggregate h4 { color: var(--orange); }
    .compare-box.ipd h4 { color: var(--blue); }

    .compare-box ul {
      list-style: none;
      font-size: 0.85rem;
      line-height: 1.8;
    }

    .compare-box li::before {
      content: "‚Ä¢ ";
      color: var(--gold);
    }

    /* Stats */
    .stats-grid {
      display: flex;
      gap: 1rem;
      margin: 1.5rem 0;
      flex-wrap: wrap;
      justify-content: center;
    }

    .stat-box {
      background: var(--navy);
      color: var(--cream);
      padding: 1rem 1.5rem;
      text-align: center;
      min-width: 130px;
      border-radius: 8px;
    }

    .stat-value {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: clamp(1.4rem, 3vw, 2rem);
      font-weight: 700;
    }

    .stat-label { font-size: 0.7rem; opacity: 0.8; margin-top: 0.25rem; }

    /* Death toll */
    .death-toll {
      background: linear-gradient(135deg, rgba(197,48,48,0.3), rgba(0,0,0,0.5));
      border: 2px solid var(--red);
      padding: 2rem;
      text-align: center;
      max-width: 400px;
      border-radius: 12px;
    }

    .death-toll .number {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 4rem;
      font-weight: 700;
      color: var(--red);
    }

    .death-toll .label {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.8);
      margin-top: 0.5rem;
    }

    /* Discovery box */
    .discovery-box {
      background: linear-gradient(135deg, rgba(59,130,246,0.3), rgba(0,0,0,0.5));
      border: 2px solid var(--blue);
      padding: 2rem;
      text-align: center;
      max-width: 450px;
      border-radius: 12px;
    }

    .discovery-box .insight {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 2rem;
      font-weight: 700;
      color: var(--blue);
    }

    .discovery-box .label {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.8);
      margin-top: 0.5rem;
    }

    /* Lesson items */
    .lesson-item {
      display: flex;
      align-items: flex-start;
      gap: 1rem;
      margin: 0.6rem 0;
      max-width: 800px;
      text-align: left;
    }

    .lesson-number {
      background: var(--gold);
      color: var(--navy);
      width: 32px;
      height: 32px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      flex-shrink: 0;
      border-radius: 4px;
    }

    .lesson-content h4 {
      font-size: 1rem;
      font-weight: 700;
      color: var(--cream);
      margin-bottom: 0.2rem;
    }

    .lesson-content p { font-size: 0.85rem; color: rgba(255,255,255,0.7); }

    /* Formula box */
    .formula-box {
      background: rgba(0,0,0,0.4);
      border: 1px solid var(--purple);
      border-radius: 8px;
      padding: 1rem 1.5rem;
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.2rem;
      text-align: center;
      max-width: 600px;
      margin: 1rem 0;
    }

    .formula-box .formula {
      color: var(--gold);
      margin: 0.5rem 0;
      font-size: 1.1rem;
    }

    .formula-box .label {
      font-size: 0.8rem;
      color: rgba(255,255,255,0.6);
      font-family: 'Source Sans Pro', sans-serif;
    }

    /* Patient silhouettes */
    .patient-grid {
      display: flex;
      flex-wrap: wrap;
      gap: 0.25rem;
      max-width: 400px;
      justify-content: center;
      padding: 1rem;
      background: rgba(0,0,0,0.3);
      border-radius: 12px;
    }

    .patient-icon {
      font-size: 1.2rem;
      opacity: 0.7;
    }

    .patient-icon.highlighted {
      opacity: 1;
      filter: drop-shadow(0 0 4px var(--gold));
    }

    .patient-icon.responder { color: var(--green); }
    .patient-icon.non-responder { color: var(--red); }
    .patient-icon.hidden { color: var(--orange); opacity: 0.4; }

    /* Timeline */
    .timeline {
      max-width: 600px;
      width: 100%;
    }

    .timeline-item {
      display: flex;
      gap: 1rem;
      margin: 1rem 0;
      padding-left: 1rem;
      border-left: 3px solid var(--gold);
    }

    .timeline-year {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.2rem;
      font-weight: 700;
      color: var(--gold);
      min-width: 60px;
    }

    .timeline-content {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.8);
    }

    /* Gold line */
    .gold-line { width: 150px; height: 2px; background: var(--gold); margin: 1.5rem auto; }

    /* Content wrapper */
    .content {
      display: flex;
      flex-direction: column;
      align-items: center;
      width: 100%;
      max-width: 1000px;
    }

    /* Animation */
    .slide.active .animate { animation: fadeUp 0.6s ease-out forwards; }
    .slide.active .animate.delay-1 { animation-delay: 0.1s; }
    .slide.active .animate.delay-2 { animation-delay: 0.2s; }
    .slide.active .animate.delay-3 { animation-delay: 0.3s; }
    .slide.active .animate.delay-4 { animation-delay: 0.4s; }
    .slide.active .animate.delay-5 { animation-delay: 0.5s; }

    @keyframes fadeUp {
      from { opacity: 0; transform: translateY(20px); }
      to { opacity: 1; transform: translateY(0); }
    }

    .animate { opacity: 0; }

    /* Slide Nav */
    .slide-nav {
      position: absolute;
      bottom: 0; left: 0; right: 0;
      display: flex;
      justify-content: space-between;
      align-items: flex-end;
      padding: 1rem 1rem 1.5rem 1rem;
      z-index: 100;
      pointer-events: none;
    }

    .nav-btn {
      background: rgba(0,0,0,0.5);
      border: 1px solid rgba(255,255,255,0.2);
      color: white;
      font-size: 1.25rem;
      cursor: pointer;
      opacity: 0.6;
      transition: all 0.2s;
      padding: 0.5rem 0.75rem;
      border-radius: 8px;
      pointer-events: auto;
    }

    .nav-btn:hover { opacity: 1; background: rgba(0,0,0,0.7); border-color: var(--gold); }

    .nav-center {
      display: flex;
      flex-direction: column;
      align-items: center;
      gap: 0.25rem;
      pointer-events: auto;
    }

    .slide-counter { color: rgba(255,255,255,0.6); font-size: 0.85rem; min-width: 50px; text-align: center; }
    .progress { display: flex; gap: 4px; flex-wrap: wrap; justify-content: center; max-width: 200px; }

    .progress-dot {
      width: 6px; height: 6px;
      border-radius: 50%;
      background: rgba(255,255,255,0.25);
      cursor: pointer;
      transition: all 0.2s;
    }

    .progress-dot.active { background: var(--gold); transform: scale(1.3); }
    .progress-dot:hover { background: rgba(255,255,255,0.6); }

    /* Quiz */
    .quiz-container {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(212,175,55,0.3);
      padding: 1.5rem;
      max-width: 700px;
      width: 100%;
      border-radius: 8px;
    }

    .quiz-question {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.2rem;
      margin-bottom: 1rem;
      color: var(--gold);
      line-height: 1.4;
    }

    .quiz-options { display: flex; flex-direction: column; gap: 0.5rem; }

    .quiz-option {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(255,255,255,0.2);
      padding: 0.75rem 1rem;
      cursor: pointer;
      transition: all 0.2s;
      text-align: left;
      border-radius: 6px;
      font-size: 0.9rem;
    }

    .quiz-option:hover { background: rgba(212,175,55,0.1); border-color: var(--gold); }
    .quiz-option.correct { background: rgba(34,197,94,0.2); border-color: var(--green); }
    .quiz-option.incorrect { background: rgba(197,48,48,0.2); border-color: var(--red); }

    .quiz-feedback {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
      font-size: 0.9rem;
    }

    .quiz-feedback.show { display: block; }
    .quiz-feedback.correct { background: rgba(34,197,94,0.2); border: 1px solid var(--green); }
    .quiz-feedback.incorrect { background: rgba(197,48,48,0.2); border: 1px solid var(--red); }

    /* Branching Scenario */
    .scenario-panel {
      background: rgba(0,0,0,0.3);
      border: 2px solid var(--purple);
      border-radius: 12px;
      padding: 1.5rem;
      max-width: 750px;
      width: 100%;
    }

    .scenario-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 1rem;
    }

    .scenario-icon { font-size: 1.5rem; }

    .scenario-title {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.3rem;
      color: var(--gold);
    }

    .scenario-situation {
      font-size: 0.95rem;
      line-height: 1.6;
      margin-bottom: 1rem;
      color: rgba(255,255,255,0.9);
    }

    .scenario-question {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.1rem;
      color: var(--gold);
      margin-bottom: 1rem;
    }

    .scenario-choices {
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }

    .scenario-choice {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(255,255,255,0.2);
      padding: 0.75rem 1rem;
      cursor: pointer;
      transition: all 0.2s;
      border-radius: 6px;
      display: flex;
      align-items: flex-start;
      gap: 0.75rem;
    }

    .scenario-choice:hover { background: rgba(212,175,55,0.1); border-color: var(--gold); }
    .scenario-choice.answered { pointer-events: none; opacity: 0.6; }
    .scenario-choice.correct { background: rgba(34,197,94,0.2); border-color: var(--green); opacity: 1; }
    .scenario-choice.incorrect { background: rgba(197,48,48,0.2); border-color: var(--red); opacity: 1; }

    .choice-letter {
      background: var(--navy);
      color: var(--gold);
      width: 24px;
      height: 24px;
      display: flex;
      align-items: center;
      justify-content: center;
      border-radius: 4px;
      font-weight: 700;
      font-size: 0.8rem;
      flex-shrink: 0;
    }

    .choice-text { font-size: 0.9rem; line-height: 1.4; }

    .scenario-consequence {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
    }

    .scenario-consequence.visible { display: block; }
    .scenario-consequence.good { background: rgba(34,197,94,0.15); border: 1px solid var(--green); }
    .scenario-consequence.bad { background: rgba(197,48,48,0.15); border: 1px solid var(--red); }
    .scenario-consequence.neutral { background: rgba(249,115,22,0.15); border: 1px solid var(--orange); }

    .consequence-title {
      font-weight: 700;
      margin-bottom: 0.5rem;
    }

    .scenario-consequence.good .consequence-title { color: var(--green); }
    .scenario-consequence.bad .consequence-title { color: var(--red); }
    .scenario-consequence.neutral .consequence-title { color: var(--orange); }

    .consequence-text { font-size: 0.9rem; line-height: 1.5; margin-bottom: 0.75rem; }
    .consequence-lesson { font-style: italic; color: var(--gold); font-size: 0.85rem; }

    /* References */
    .references {
      background: rgba(0,0,0,0.3);
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 8px;
      padding: 1.5rem;
      max-width: 700px;
      text-align: left;
      font-size: 0.75rem;
      line-height: 1.8;
    }

    .references h4 {
      color: var(--gold);
      font-size: 0.9rem;
      margin-bottom: 1rem;
    }

    .references ol { padding-left: 1.5rem; }
    .references li { margin-bottom: 0.5rem; color: rgba(255,255,255,0.8); }
    .references .journal { font-style: italic; }

    .text-center { text-align: center; }
    .mb-1 { margin-bottom: 1rem; }
    .mb-2 { margin-bottom: 2rem; }
    .mt-1 { margin-top: 1rem; }
    .mt-2 { margin-top: 2rem; }

    /* Interactive element focus states */
    .module-item:focus-visible {
      background: rgba(212,175,55,0.2);
      outline: 2px solid var(--gold);
      outline-offset: -2px;
    }
    .nav-btn:focus-visible {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
      opacity: 1;
    }
    .progress-dot:focus-visible {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
      transform: scale(1.5);
    }
    .quiz-option:focus-visible,
    .scenario-choice:focus-visible {
      outline: 2px solid var(--gold);
      outline-offset: 2px;
      background: rgba(212,175,55,0.15);
    }

    /* High contrast mode support */
    @media (prefers-contrast: high) {
      :root {
        --gold: #FFD700;
        --cream: #FFFFFF;
        --text: #000000;
      }
      .btn { border-width: 2px; }
      .slide.dark, .slide.black { background: #000; }
    }

    /* Print stylesheet */
    @media print {
      .sidebar, .content-header, .slide-nav, .header-actions { display: none !important; }
      .course-container { display: block; height: auto; }
      .main-content { overflow: visible; }
      .content-body { overflow: visible; }
      .slides-container { overflow: visible; position: static; }
      .module-slides { display: block !important; }
      .slide {
        position: static !important;
        opacity: 1 !important;
        visibility: visible !important;
        page-break-inside: avoid;
        page-break-after: always;
        min-height: 100vh;
        background: white !important;
        color: black !important;
      }
      .slide * { color: black !important; }
      .title { color: #1E2761 !important; }
      .refrain, .gold-line { color: #8B7500 !important; }
      .simple-box, .story-card, .decision-tree, .compare-box {
        border: 2px solid #333 !important;
        background: #f5f5f5 !important;
      }
    }

    /* Light theme */
    body.light-theme {
      --deep-navy: #f5f5f5;
      --navy: #e8e8e8;
      --cream: #1a1a2e;
      --text: #2D3748;
      --light-text: #4a5568;
    }
    body.light-theme .sidebar {
      background: linear-gradient(180deg, #f0f0f0 0%, #e0e0e0 100%);
      border-right-color: rgba(30,39,97,0.2);
    }
    body.light-theme .sidebar-header h1 { color: var(--navy); }
    body.light-theme .module-item:hover { background: rgba(30,39,97,0.1); }
    body.light-theme .module-item.active { background: rgba(30,39,97,0.15); border-left-color: #1E2761; }
    body.light-theme .module-number { background: rgba(30,39,97,0.1); color: #1E2761; }
    body.light-theme .module-item.active .module-number { background: #1E2761; color: white; }
    body.light-theme .module-title { color: #1a1a2e; }
    body.light-theme .module-subtitle { color: #4a5568; }
    body.light-theme .content-header { background: rgba(0,0,0,0.05); border-bottom-color: rgba(30,39,97,0.2); }
    body.light-theme .breadcrumb { color: #4a5568; }
    body.light-theme .breadcrumb span { color: #1E2761; }
    body.light-theme .btn { background: rgba(30,39,97,0.05); color: #1a1a2e; border-color: rgba(30,39,97,0.3); }
    body.light-theme .btn:hover { background: rgba(30,39,97,0.15); }
    body.light-theme .btn.primary { background: #1E2761; color: white; }
    body.light-theme .slide.dark,
    body.light-theme .slide.black,
    body.light-theme .slide.gradient,
    body.light-theme .slide.blood,
    body.light-theme .slide.hope,
    body.light-theme .slide.ipd,
    body.light-theme .slide.precision {
      background: #fafafa;
      color: #1a1a2e;
    }
    body.light-theme .title.gold { color: #1E2761; }
    body.light-theme .title.cream { color: #1a1a2e; }
    body.light-theme .refrain { color: #1E2761; }
    body.light-theme .refrain.warning { color: #C53030; border-left-color: #C53030; }
    body.light-theme .refrain.hope { color: #166534; }
    body.light-theme .refrain.insight { color: #1E40AF; }
    body.light-theme .rhetorical { color: #1a1a2e; }
    body.light-theme .rhetorical em { color: #1E2761; }
    body.light-theme .simple-box { background: linear-gradient(135deg, rgba(0,212,170,0.1), rgba(240,240,240,0.8)); }
    body.light-theme .story-card { background: rgba(0,0,0,0.03); }
    body.light-theme .story-card .narrative { color: #2D3748; }
    body.light-theme .decision-tree { background: rgba(0,0,0,0.03); }
    body.light-theme .nav-btn { background: rgba(0,0,0,0.1); color: #1a1a2e; border-color: rgba(0,0,0,0.2); }
    body.light-theme .slide-counter { color: #4a5568; }
    body.light-theme .progress-dot { background: rgba(0,0,0,0.2); }
    body.light-theme .progress-dot.active { background: #1E2761; }
    body.light-theme .sidebar-footer { color: #4a5568; }
    body.light-theme .gold-line { background: #1E2761; }

    /* Certificate Modal */
    .certificate-modal {
      display: none;
      position: fixed;
      top: 0;
      left: 0;
      width: 100%;
      height: 100%;
      background: rgba(0,0,0,0.8);
      z-index: 2000;
      align-items: center;
      justify-content: center;
    }
    .certificate-modal.visible { display: flex; }
    .certificate {
      background: linear-gradient(135deg, #faf8f5 0%, #fff 100%);
      border: 8px solid #D4AF37;
      border-radius: 12px;
      padding: 3rem;
      max-width: 700px;
      width: 90%;
      text-align: center;
      position: relative;
      box-shadow: 0 25px 50px rgba(0,0,0,0.3);
    }
    .certificate-header {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 2.5rem;
      color: #1E2761;
      margin-bottom: 0.5rem;
    }
    .certificate-subtitle {
      font-size: 1rem;
      color: #718096;
      margin-bottom: 2rem;
      letter-spacing: 0.2em;
      text-transform: uppercase;
    }
    .certificate-body {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.2rem;
      color: #2D3748;
      line-height: 1.8;
      margin-bottom: 2rem;
    }
    .certificate-name {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 2rem;
      font-weight: 700;
      color: #1E2761;
      border-bottom: 2px solid #D4AF37;
      display: inline-block;
      padding: 0 2rem 0.5rem;
      margin: 1rem 0;
    }
    .certificate-date {
      font-size: 0.9rem;
      color: #718096;
      margin-top: 1.5rem;
    }
    .certificate-seal {
      width: 80px;
      height: 80px;
      background: linear-gradient(135deg, #D4AF37, #B8860B);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      margin: 1.5rem auto 0;
      color: white;
      font-size: 2rem;
      box-shadow: 0 4px 15px rgba(212,175,55,0.4);
    }
    .certificate-actions {
      margin-top: 2rem;
      display: flex;
      gap: 1rem;
      justify-content: center;
    }
    .certificate-actions button {
      padding: 0.75rem 1.5rem;
      border: 2px solid #1E2761;
      border-radius: 6px;
      background: white;
      color: #1E2761;
      font-size: 0.9rem;
      cursor: pointer;
      transition: all 0.2s;
    }
    .certificate-actions button:hover {
      background: #1E2761;
      color: white;
    }
    .certificate-actions button.primary {
      background: #1E2761;
      color: white;
    }
    .certificate-close {
      position: absolute;
      top: 1rem;
      right: 1rem;
      background: none;
      border: none;
      font-size: 1.5rem;
      cursor: pointer;
      color: #718096;
    }
    .certificate-close:hover { color: #1E2761; }

    /* Name input for certificate */
    .certificate-input {
      font-family: 'Cormorant Garamond', Georgia, 'Times New Roman', serif;
      font-size: 1.5rem;
      text-align: center;
      border: none;
      border-bottom: 2px solid #D4AF37;
      background: transparent;
      padding: 0.5rem 1rem;
      width: 80%;
      max-width: 300px;
      color: #1E2761;
    }
    .certificate-input:focus {
      outline: none;
      border-bottom-color: #1E2761;
    }
    .mobile-menu-toggle{display:none;position:fixed;top:12px;left:12px;z-index:1001;background:#1E2761;border:1px solid #D4AF37;color:#D4AF37;width:40px;height:40px;border-radius:8px;font-size:1.2rem;cursor:pointer;align-items:center;justify-content:center;}
    @media(max-width:768px){.mobile-menu-toggle{display:flex;}.sidebar{transform:translateX(-100%);transition:transform 0.3s ease;position:fixed;z-index:1000;height:100vh;}.sidebar.open{transform:translateX(0);}.sidebar-overlay{display:none;position:fixed;inset:0;background:rgba(0,0,0,0.5);z-index:999;}.sidebar-overlay.show{display:block;}}
  </style>
</head>
<body>
<!-- Skip link for keyboard navigation -->
<a class="skip-link" href="#main-content">Skip to content</a>
<button aria-expanded="false" aria-label="Toggle navigation menu" class="mobile-menu-toggle" onclick="toggleSidebar()">‚ò∞</button>
<div class="sidebar-overlay" onclick="document.querySelector('.sidebar').classList.remove('open');this.classList.remove('show');"></div>
<!-- Live region for screen reader announcements -->
<div aria-atomic="true" aria-live="polite" class="aria-live-region" id="ariaLiveRegion"></div>
<!-- Certificate Modal -->
<div aria-labelledby="certTitle" aria-modal="true" class="certificate-modal" id="certificateModal" role="dialog">
<div class="certificate" id="certificateContent">
<button aria-label="Chiudi certificato" class="certificate-close" onclick="closeCertificate()">√ó</button>
<div class="certificate-header" id="certTitle">Certificate of Completion</div>
<div class="certificate-subtitle">Meta-analisi dei dati dei singoli partecipanti</div>
<div class="certificate-body">
        Questo certifica che<br/>
<input aria-label="Il tuo nome per il certificato" class="certificate-input" id="certName" placeholder="Inserisci il tuo nome" type="text"/>
<br/><br/>
        ha completato con successo il corso<br/>
<strong>"The Hidden Patient: IPD Meta-Analysis"</strong><br/>
        demonstrating understanding of individual participant data<br/>
        metodi di sintesi e i loro risultati clinici applicazioni.
      </div>
<div class="certificate-date" id="certDate"></div>
<div class="certificate-seal">‚úì</div>
<div class="certificate-actions">
<button aria-label="Stampa certificato" onclick="printCertificate()">üñ®Ô∏è Print</button>
<button aria-label="Scarica certificato come immagine" class="primary" onclick="downloadCertificate()">üì• Download</button>
</div>
</div>
</div>
<div aria-label="Meta-analisi IPD Corso" class="course-container">
<!-- Sidebar Navigation -->
<nav aria-label="Moduli del corso" class="sidebar" role="navigation">
<div class="sidebar-header">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;">‚Üê Course Library</a>
<h1>Il paziente nascosto</h1>
<p>Meta-analisi dei dati dei singoli partecipanti</p>
</div>
<div aria-label="Elenco moduli" class="module-list" id="moduleList" role="list"></div>
<div class="sidebar-footer">
<div aria-live="polite" id="progressPercent" style="color:var(--gold);margin-bottom:0.5rem;font-weight:600;"></div>
        "Nel complesso, l'individuo scompare."
        <br/><br/>
        Ogni paziente ha una storia. IPD ti consente di ascoltarlo.
        <br/><br/>
<details style="font-size:0.65rem;opacity:0.7;">
<summary style="cursor:pointer;">Keyboard shortcuts</summary>
<div style="margin-top:0.5rem;">
            ‚Üí / Space: Next slide<br/>
            ‚Üê: Previous slide<br/>
            Home: Primo modulo<br/>
            Fine: Ultimo modulo
          </div>
</details>
</div>
</nav>
<!-- Main Content -->
<main class="main-content" role="main">
<header class="content-header">
<div class="breadcrumb">
          IPD Course &gt; <span id="currentModule">The Vanishing</span>
</div>
<div aria-label="Azioni del corso" class="header-actions" role="toolbar">
<button aria-label="Toggle theme" class="btn" id="themeToggle" onclick="toggleTheme()" title="Toggle light/dark mode">‚òÄÔ∏è</button>
<button aria-label="Reimposta avanzamento del corso" class="btn" onclick="resetProgress()" title="Ricomincia dall'inizio">Reset</button>
<button aria-label="Vai ai riferimenti modulo" class="btn" onclick="goToModule(16)">References</button>
<button aria-label="Continue to next slide" class="btn primary" onclick="nextSlide()">Continue</button>
</div>
</header>
<div class="content-body">
<div aria-label="Corso slides" class="slides-container" id="main-content" role="region" tabindex="-1">
 ==================== MODULO 1: LA VANISHING (PERCH√â IPD √à IMPORTANTE) ==================== 
<div class="module-slides active" data-module="1">
<!-- Slide 1.1: Opening -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non avete visto come vengono cancellate migliaia di pazienti<br/>
                  can be <em>reduced to a single number</em>,<br/>
                  e in quel numero, <em>vite vengono cancellate</em>?
                </div>
</div>
</div>
 Diapositiva 1.2: L'aggregato Illusione 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">L'illusione aggregata</div>
<div class="story-card animate delay-1">
<div class="place">EVERY META-ANALYSIS YOU'VE EVER READ</div>
<div class="narrative">
                    A meta-analysis reports: "Treatment reduces mortality by 15%."
                    <br/><br/>
                    Ma quali pazienti ne hanno beneficiato? I giovani o gli anziani? Quelli con malattia lieve o grave? Uomini o donne?
                    <br/><br/>
<strong>L'aggregato non pu√≤ rispondere.</strong>
<br/><br/>
                    In media, alcuni pazienti sono stati salvati e altri sono stati danneggiati.
                  </div>
</div>
</div>
</div>
 Diapositiva 1.3: L'eterogeneit√† nascosta 
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">What Aggregates Hide</div>
<div class="patient-grid animate delay-1">
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon non-responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon non-responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon non-responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon non-responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon non-responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon non-responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
<span class="patient-icon non-responder">‚óè</span>
<span class="patient-icon responder">‚óè</span>
</div>
<p class="animate delay-2" style="margin-top:1rem;font-size:0.9rem;">
<span style="color:var(--green);">‚óè Responders</span> ¬†
                  <span style="color:var(--red);">‚óè Non-responders</span>
</p>
<div class="simple-box animate delay-3">
<div class="simple-title">THE TRAGEDY</div>
<div class="simple-text">
                    "Overall benefit: 30%"<br/><br/>
                    But <strong>who</strong> sono il 30%? Senza dati individuali, non possiamo identificare i rispondenti dai non rispondenti. Non possiamo esercitarci <strong>precision medicine</strong>.
                  </div>
</div>
</div>
</div>
<!-- Slide 1.4: The Breast Cancer Revelation -->
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">Oxford, 1985</div>
<div class="story-card animate delay-1">
<div class="place">EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP</div>
<div class="narrative">
                    Richard Peto gathered something unprecedented: the <strong>raw data</strong>
                    on every woman in every tamoxifen trial.
                    <br/><br/>
                    Non con riassunti. Non medie. <strong>Each patient, each tumor, each outcome.</strong>
<br/><br/>
                    What he discovered changed breast cancer treatment forever.
                  </div>
<div class="source">Early Breast Cancer Trialists' Collaborative Group. Lancet 1988;2:61-72</div>
</div>
</div>
</div>
 Diapositiva 1.5: La scoperta 
<div class="slide dark">
<div class="content text-center">
<div class="rhetorical animate">
                  Gli studi pubblicati dicevano:<br/>
                  "Tamoxifen works."
                  <br/><br/>
                  But the <em>individual data</em> revealed:
                </div>
<div class="discovery-box animate delay-2">
<div class="insight">ER+ vs ER‚àí</div>
<div class="label">Tamoxifen only worked in estrogen receptor positive tumors</div>
</div>
<div class="simple-box animate delay-3">
<div class="simple-title">COSA ERA NASCOSTO</div>
<div class="simple-text">
                    Nessun singolo studio era abbastanza grande da rilevare questa interazione. Solo combinando <strong>i dati dei singoli pazienti</strong> da tutti gli studi potrebbe emergere la verit√†:<br/><br/>
<strong>Giving tamoxifen to ER‚àí patients was useless.</strong>
</div>
</div>
</div>
</div>
 Diapositiva 1.6: Il ritornello 
<div class="slide black">
<div class="content text-center">
<div class="refrain insight animate">
                  "Nell'aggregato, i singoli pazienti scompare.<br/>
                  Nell'individuo, la verit√† appare.<br/>
                  Ecco perch√© cerchiamo il paziente nascosto."
                </div>
<div class="gold-line animate delay-2"></div>
<p class="animate delay-3" style="color:rgba(255,255,255,0.6);font-style:italic;">
                  Questa √® la meta-analisi dei dati dei singoli partecipanti.
                </p>
</div>
</div>
</div>
 ==================== MODULO 2: AGGREGATE VS IPD ==================== 
<div class="module-slides" data-module="2">
<!-- Slide 2.1: Opening -->
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  What is lost when we summarize?<br/>
                  What is found when we look closer?
                </div>
</div>
</div>
 Diapositiva 2.2: I due approcci 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Two Ways to Synthesize</div>
<div class="compare-grid animate delay-1">
<div class="compare-box aggregate">
<h4>Aggregate Data (AD)</h4>
<ul>
<li>Study-level summaries</li>
<li>Dimensioni degli effetti dalle pubblicazioni</li>
<li>Mean age, % male, etc.</li>
<li>Rapido e accessibile</li>
<li>Cannot see within-study variation</li>
</ul>
</div>
<div class="compare-box ipd">
<h4>Dati individuali dei partecipanti (IPD)</h4>
<ul>
<li>Dati grezzi a livello di paziente</li>
<li>Every participant's characteristics</li>
<li>Actual ages, actual outcomes</li>
<li>Time-intensive to obtain</li>
<li>Can see who responds and who doesn't</li>
</ul>
</div>
</div>
</div>
</div>
 Diapositiva 2.3: L'errore ecologico 
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">L'errore ecologico</div>
<div class="story-card animate delay-1">
<div class="place">IL PERICOLO DEL PENSIERO AGGREGATO</div>
<div class="narrative">
                    Imagine two trials of a drug for heart failure.
                    <br/><br/>
                    Trial A: Mean age 55 years, Effect size 0.70 (benefit)<br/>
                    Trial B: Mean age 75 years, Effect size 0.90 (less benefit)
                    <br/><br/>
<strong>Tempting conclusion:</strong> "The drug works better in younger patients."
                    <br/><br/>
<strong>But this could be completely wrong.</strong>
</div>
</div>
</div>
</div>
<!-- Slide 2.4: Why It's Wrong -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">The Trap</div>
<div class="simple-box animate delay-1">
<div class="simple-title">ECOLOGICAL FALLACY</div>
<div class="simple-text">
                    All'interno di ogni studio, la relazione tra et√† ed effetto del trattamento potrebbe derivare <strong>completely different</strong> dalla relazione tra gli studi.
                    <br/><br/>
                    Perhaps in Trial A, <em>older</em> patients within that trial responded better.
                    Perhaps in Trial B, <em>younger</em> patients within that trial responded better.
                    <br/><br/>
<strong>Non √® possibile saperlo senza l'individuo dati.</strong>
</div>
</div>
<div class="formula-box animate delay-2">
<div class="label">THE RULE</div>
<div class="formula">Between-study relationships ‚â† Within-study relationships</div>
<div class="label">Aggregate data can only show between-study patterns</div>
</div>
</div>
</div>
<!-- Slide 2.5: What IPD Enables -->
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">What IPD Enables</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number" style="background:var(--blue);">1</div>
<div class="lesson-content">
<h4>True Effect Modification</h4>
<p>Test whether treatment effect varies by patient characteristics (age, biomarkers, disease severity)</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number" style="background:var(--blue);">2</div>
<div class="lesson-content">
<h4>Time-to-Event Analysis</h4>
<p>Use actual survival curves, not just hazard ratios. Handle censoring properly.</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number" style="background:var(--blue);">3</div>
<div class="lesson-content">
<h4>Consistent Definitions</h4>
<p>Standardize outcome definitions, exposure timing, covariate categories across studies</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number" style="background:var(--blue);">4</div>
<div class="lesson-content">
<h4>Subgroup Credibility</h4>
<p>Testare le interazioni all'interno degli studi, evitando l'errore ecologico</p>
</div>
</div>
</div>
</div>
<!-- Slide 2.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "I dati aggregati mostrano la foresta.<br/>
                  Individual data shows each tree.<br/>
                  Se hai bisogno di sapere quali alberi sono malato‚Äî<br/>
                  you must walk among them."
                </div>
</div>
</div>
</div>
 ==================== MODULO 3: LA RIVELAZIONE CTT (STATINE) ==================== 
<div class="module-slides" data-module="3">
<!-- Slide 3.1: Opening -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai visto come <em>one collaboration</em><br/>
                  gathered data on <em>170,000 patients</em><br/>
                  and answered questions no single trial could ask?
                </div>
</div>
</div>
 Slide 3.2: Il CTT 
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">Oxford, 1994-Present</div>
<div class="story-card animate delay-1">
<div class="place">CHOLESTEROL TREATMENT TRIALISTS' COLLABORATION</div>
<div class="narrative">
                    Il CTT ha raccolto dati individuali da <strong>every major statin trial</strong>.
                    <br/><br/>
                    27 trials. 174,149 patients. Every baseline characteristic.
                    Every cardiovascular event. Every death.
                    <br/><br/>
                    The published trials asked: "Do statins work?"
                    <br/><br/>
                    Il CTT ha chiesto: <strong>"Per chi funzionano le statine?"</strong>
</div>
<div class="source">CTT Collaboration. Lancet 2010;376:1670-81</div>
</div>
</div>
</div>
 Diapositiva 3.3: Il Numeri 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La scala dell'IPD</div>
<div class="stats-grid animate delay-1">
<div class="stat-box">
<div class="stat-value" style="color:var(--blue);">27</div>
<div class="stat-label">Trials Combined</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--gold);">174,149</div>
<div class="stat-label">Individual Patients</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--teal);">5</div>
<div class="stat-label">Anni di raccolta dati</div>
</div>
</div>
<div class="simple-box blue animate delay-2">
<div class="simple-title">THE INVESTMENT</div>
<div class="simple-text">
                    La raccolta dell'IPD richiede anni di negoziazione, trasferimento dei dati, pulizia e armonizzazione.
                    <br/><br/>
                    Ma le domande a cui puoi rispondere <strong>vale l'investimento</strong>.
                  </div>
</div>
</div>
</div>
 Diapositiva 3.4: La scoperta 
<div class="slide precision">
<div class="content text-center">
<div class="title purple animate">What CTT Discovered</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number" style="background:var(--green);">‚úì</div>
<div class="lesson-content">
<h4>Benefit Proportional to LDL Reduction</h4>
<p>Every 1 mmol/L LDL reduction = 22% lower CV events. True across all subgroups.</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number" style="background:var(--green);">‚úì</div>
<div class="lesson-content">
<h4>No Age Threshold</h4>
<p>Benefit continues even in patients &gt;75 years (contradicting earlier AD analyses)</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number" style="background:var(--green);">‚úì</div>
<div class="lesson-content">
<h4>Primary Prevention Works</h4>
<p>Patients without prior CVD benefit proportionally to their baseline risk</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number" style="background:var(--red);">‚úó</div>
<div class="lesson-content">
<h4>No Cancer Signal</h4>
<p>Le preoccupazioni sulle statine che causano il cancro sono state definitivamente confutate con il follow-up dell'IPD</p>
</div>
</div>
</div>
</div>
 Diapositiva 3.5: Perch√© l'AD non √® riuscito Risposta 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Perch√© i dati aggregati non sono riusciti</div>
<div class="story-card animate delay-1">
<div class="place">THE LIMITATION</div>
<div class="narrative">
                    Published trials categorized patients differently.
                    <br/><br/>
                    Trial A: "High risk" = 10-year CVD risk &gt;20%<br/>
                    Trial B: "High risk" = Prior MI<br/>
                    Trial C: "High risk" = Diabetes
                    <br/><br/>
                    You cannot compare or combine what is defined differently.
                    <br/><br/>
<strong>IPD allowed the CTT to redefine everyone consistently.</strong>
</div>
</div>
</div>
</div>
<!-- Slide 3.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain hope animate">
                  "When trials speak different languages,<br/>
                  IPD fornisce la traduzione.<br/>
                  What seemed contradictory becomes clear:<br/>
                  the same truth, measured differently."
                </div>
</div>
</div>
</div>
<!-- ==================== MODULE 4: WHEN TO PURSUE IPD (DECISION TREE) ==================== -->
<div class="module-slides" data-module="4">
<!-- Slide 4.1: Opening -->
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  IPD takes <em>years</em> to gather.<br/>
                  I dati aggregati richiedono <em>weeks</em>.<br/>
<br/>
                  Quando vale la pena investire?
                </div>
</div>
</div>
 Diapositiva 4.2: La decisione Quadro 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">L'albero decisionale</div>
<div class="decision-tree animate delay-1">
<h4>Dovresti perseguire l'IPD?</h4>
<div class="tree-level">
<div class="tree-node root">La tua domanda √® sulla modifica dell'effetto del trattamento?</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 2rem;">
<div>
<div class="tree-node yes">YES</div>
<div class="tree-label">"Who benefits most?"</div>
</div>
<div>
<div class="tree-node no">NO</div>
<div class="tree-label">"Does it work overall?"</div>
</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 2rem;">
<div class="tree-node ipd">IPD likely needed</div>
<div class="tree-node aggregate">AD may suffice</div>
</div>
</div>
</div>
</div>
<!-- Slide 4.3: More Criteria -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">When IPD Is Essential</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number">1</div>
<div class="lesson-content">
<h4>Time-to-Event Outcomes</h4>
<p>Quando le curve di sopravvivenza contano, non solo gli rapporti di rischio finali.</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number">2</div>
<div class="lesson-content">
<h4>Continuous Effect Modifiers</h4>
<p>Testing whether treatment effect varies by age, BMI, biomarker level (not just "high" vs "low")</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number">3</div>
<div class="lesson-content">
<h4>Outcome Definition Problems</h4>
<p>Quando gli studi clinici definiscono i risultati in modo diverso e ne hai bisogno. standardizzare</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number">4</div>
<div class="lesson-content">
<h4>Longer Follow-Up Available</h4>
<p>Quando gli sperimentatori hanno dati di follow-up non pubblicati che si desidera includere</p>
</div>
</div>
</div>
</div>
<!-- Slide 4.4: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-ipd-decision">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">La decisione sulla strategia di ricerca</span>
</div>
<div class="scenario-situation">
                    Stai pianificando una meta-analisi dei corticosteroidi per la polmonite da COVID-19. Hai 10 studi randomizzati idonei con dati pubblicati. Un collega chiede: "Dovremmo provare a ottenere IPD o eseguire semplicemente un'analisi aggregata?"
                    <br/><br/>
                    La tua domanda chiave √®: "I benefici variano in base alla gravit√† della malattia e ai tempi del trattamento?"
                  </div>
<div class="scenario-question">Cosa consiglia?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('ipd-decision', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">Basta eseguire l'AD: abbiamo bisogno di risultati rapidi e l'IPD richiede troppo tempo</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('ipd-decision', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">Perseguire l'IPD: il nostro la domanda riguarda la modifica dell'effetto in base alle caratteristiche del paziente</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('ipd-decision', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">Effettuare l'analisi dei sottogruppi in base alle categorie di gravit√† a livello di studio dalle pubblicazioni</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-ipd-decision"></div>
</div>
</div>
</div>
<!-- Slide 4.5: When AD Is Enough -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Quando i dati aggregati sono sufficienti</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number" style="background:var(--orange);">‚úì</div>
<div class="lesson-content">
<h4>Overall Treatment Effect</h4>
<p>Quando la tua unica domanda √® "Funziona?" non "Per chi?"</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number" style="background:var(--orange);">‚úì</div>
<div class="lesson-content">
<h4>Homogeneous Population</h4>
<p>When trials enrolled similar patients and effect modification is unlikely</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number" style="background:var(--orange);">‚úì</div>
<div class="lesson-content">
<h4>Binary Outcomes, Short Follow-up</h4>
<p>Quando la censura non √® un problema e i risultati sono semplici s√¨/no</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number" style="background:var(--orange);">‚úì</div>
<div class="lesson-content">
<h4>IPD Unobtainable</h4>
<p>Quando i trialisti non condividono, i dati vengono persi o le risorse non sono disponibili</p>
</div>
</div>
</div>
</div>
<!-- Slide 4.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "Non tutte le domande richiedono l'individuo.<br/>
                  Ma ogni domanda su <em>which</em> individuals<br/>
                  richiede la loro presenza nei tuoi dati."
                </div>
</div>
</div>
</div>
 ==================== MODULO 5: UNO STADIO VS DUE STADI ==================== 
<div class="module-slides" data-module="5">
<!-- Slide 5.1: Opening -->
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  Hai raccolto i dati individuali.<br/>
<br/>
                  Ora: analizzarli come <em>one combined dataset</em><br/>
                  or <em>trial by trial, then combine</em>?
                </div>
</div>
</div>
<!-- Slide 5.2: Two Approaches -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Two Analytical Approaches</div>
<div class="compare-grid animate delay-1">
<div class="compare-box aggregate">
<h4>Two-Stage Approach</h4>
<ul>
<li>Stage 1: Analyze each trial separately</li>
<li>Fase 2: meta-analizzare i risultati</li>
<li>Preserves trial structure</li>
<li>Familiar (like standard MA)</li>
<li>Cannot handle sparse data well</li>
</ul>
</div>
<div class="compare-box ipd">
<h4>One-Stage Approach</h4>
<ul>
<li>Analizzare tutti i dati contemporaneamente</li>
<li>Mixed-effects regression model</li>
<li>Effetti casuali per clustering</li>
<li>Meglio per dati sparsi</li>
<li>More flexible modeling</li>
</ul>
</div>
</div>
</div>
</div>
<!-- Slide 5.3: Two-Stage Explained -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Due fasi: il percorso familiare</div>
<div class="formula-box animate delay-1">
<div class="label">STAGE 1 (Within Each Trial)</div>
<div class="formula">Estimate treatment effect for trial k: Œ∏<sub>k</sub></div>
<div class="label">Utilizzo dei dati dei singoli pazienti provenienti da quello studio</div>
</div>
<div class="formula-box animate delay-2">
<div class="label">STAGE 2 (Across Trials)</div>
<div class="formula">Meta-analyze Œ∏<sub>1</sub>, Œ∏<sub>2</sub>, ... Œ∏<sub>K</sub></div>
<div class="label">Utilizzo di metodi standard a effetti casuali</div>
</div>
<div class="simple-box animate delay-3">
<div class="simple-title">ADVANTAGE</div>
<div class="simple-text">
                    Easy to understand. Easy to explain.
                    <br/>
                    Each trial's estimate is transparent.
                    <br/>
                    Familiare forest plot e io<sup>2</sup> statistics.
                  </div>
</div>
</div>
</div>
<!-- Slide 5.4: One-Stage Explained -->
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">One-Stage: Il Potente Sentiero</div>
<div class="formula-box animate delay-1">
<div class="label">MIXED-EFFECTS MODEL</div>
<div class="formula">Y<sub>ij</sub> = Œ≤<sub>0</sub> + Œ≤<sub>1</sub>Treatment<sub>ij</sub> + u<sub>j</sub> + Œµ<sub>ij</sub></div>
<div class="label">i = patient, j = trial, u<sub>j</sub> = random trial effect</div>
</div>
<div class="simple-box blue animate delay-2">
<div class="simple-title">ADVANTAGES</div>
<div class="simple-text">
<strong>1.</strong> Handles trials with zero events (no continuity corrections)<br/>
<strong>2.</strong> More powerful for detecting interactions<br/>
<strong>3.</strong> Can model complex covariate relationships<br/>
<strong>4.</strong> Exact likelihood (no normal approximations)
                  </div>
</div>
</div>
</div>
<!-- Slide 5.5: Decision Tree -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Scegli il tuo approccio</div>
<div class="decision-tree animate delay-1">
<h4>One-Stage or Two-Stage?</h4>
<div class="tree-level">
<div class="tree-node question">Do trials have sparse events (rare outcomes)?</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 2rem;">
<div>
<div class="tree-node yes">YES (sparse)</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-node ipd">One-stage preferred</div>
<div class="tree-label">Avoids zero-cell problems</div>
</div>
<div>
<div class="tree-node no">NO (common events)</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-node aggregate">Either works</div>
<div class="tree-label">I risultati dovrebbero essere simili</div>
</div>
</div>
</div>
</div>
</div>
<!-- Slide 5.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "The two-stage preserves each trial's voice.<br/>
                  The one-stage hears all voices at once.<br/>
                  Quando i dati sono scarsi e gli eventi sono rari‚Äî<br/>
                  il one-stage coglie ci√≤ che il due-stage manca."
                </div>
</div>
</div>
</div>
 ==================== MODULO 6: LA STORIA DEL TIMING DEI CORTICOSTEROIDI ==================== 
<div class="module-slides" data-module="6">
<!-- Slide 6.1: Opening -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai sentito la storia del farmaco<br/>
                  che ha salvato la vita dei bambini‚Äî<br/>
<em>but only if given at the right time</em>?
                </div>
</div>
</div>
<!-- Slide 6.2: Preterm Birth -->
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">Il paradosso del pretermine</div>
<div class="story-card animate delay-1">
<div class="place">NEONATAL INTENSIVE CARE UNITS WORLDWIDE</div>
<div class="narrative">
                    I corticosteroidi prenatali riducono la mortalit√† nei neonati pretermine Questo √® stato stabilito negli anni '70.
                    <br/><br/>
                    But a puzzle remained: <strong>When should they be given?</strong>
<br/><br/>
                    24 hours before birth? 48 hours? A week?
                    <br/><br/>
                    Published trials couldn't answer‚Äîthey didn't report timing consistently.
                  </div>
<div class="source">Roberts D, et al. Cochrane Database Syst Rev 2017</div>
</div>
</div>
</div>
 Diapositiva 6.3: L'IPD. Soluzione 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">L'IPD ha rivelato la finestra</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="border: 2px solid var(--green);">
<div class="stat-value" style="color:var(--green);">24h-7d</div>
<div class="stat-label">Optimal Window</div>
</div>
<div class="stat-box" style="border: 2px solid var(--red);">
<div class="stat-value" style="color:var(--red);">&gt;7 days</div>
<div class="stat-label">Benefit Wanes</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE DISCOVERY</div>
<div class="simple-text">
                    By examining each baby's exact time from steroid to delivery,
                    IPD meta-analysis showed:
                    <br/><br/>
<strong>Maximum benefit:</strong> 24 hours to 7 days before birth<br/>
<strong>Reduced benefit:</strong> &gt;7 days (lung maturity effect fades)<br/>
<strong>No benefit:</strong> &lt;24 hours (not enough time to work)
                  </div>
</div>
</div>
</div>
<!-- Slide 6.4: Clinical Impact -->
<div class="slide hope">
<div class="content text-center">
<div class="title green animate">Lives Saved, Practice Changed</div>
<div class="story-card animate delay-1">
<div class="place">L'IMPATTO CLINICO</div>
<div class="narrative">
                    Prima dell'IPD: i medici somministravano steroidi e speravano per il meglio.
                    <br/><br/>
                    After IPD: Guidelines now recommend <strong>repeat dosing</strong>
                    se il parto non √® avvenuto entro 7 giorni dal primo corso.
                    <br/><br/>
                    Questa precisione, impossibile senza dati individuali, ha <strong>saved thousands of premature babies</strong>.
                  </div>
</div>
<div class="discovery-box animate delay-2">
<div class="insight">Timing is Treatment</div>
<div class="label">Lo stesso farmaco, somministrato nel momento sbagliato, potrebbe anche essere un placebo</div>
</div>
</div>
</div>
<!-- Slide 6.5: Why AD Failed -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Perch√© i dati aggregati non potrebbero mostrarlo</div>
<div class="simple-box animate delay-1">
<div class="simple-title">THE PROBLEM</div>
<div class="simple-text">
                    Trial A reported: "Steroid given within 48 hours"<br/>
                    Trial B reported: "Steroid given antenatally"<br/>
                    Trial C reported: "Steroid-to-delivery interval: median 3 days"
                    <br/><br/>
                    Different categories. Different definitions. <strong>Incompatible summaries.</strong>
<br/><br/>
                    Only by examining each baby's actual steroid-to-delivery time
                    could the optimal window be identified.
                  </div>
</div>
</div>
</div>
<!-- Slide 6.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain hope animate">
                  "Il farmaco era noto lavoro.<br/>
                  But <em>when</em> darlo era sconosciuto.<br/>
                  IPD ha trasformato 'qualche volta' in 'il momento giusto'‚Äî<br/>
                  e in quella precisione, i bambini vivevano."
                </div>
</div>
</div>
</div>
 ==================== MODULO 7: OTTENERE IPD (LA RICERCA) ==================== 
<div class="module-slides" data-module="7">
<!-- Slide 7.1: Opening -->
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  I dati esistono.<br/>
                  Da qualche parte, in file e database,<br/>
<em>la storia di ogni paziente viene registrata</em>.<br/>
<br/>
                  La domanda √®: la condivideranno?
                </div>
</div>
</div>
 Diapositiva 7.2: Il Quest 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La ricerca dei dati</div>
<div class="stats-grid animate delay-1">
<div class="stat-box">
<div class="stat-value" style="color:var(--green);">60-80%</div>
<div class="stat-label">Typical IPD Retrieval Rate</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--red);">6-24</div>
<div class="stat-label">Months to Gather</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">REALITY CHECK</div>
<div class="simple-text">
                    Probabilmente <strong>not</strong> get 100% of trials.
                    Some investigators will refuse. Some data is lost.
                    Some companies won't share.
                    <br/><br/>
<strong>This is expected.</strong> Plan for it.
                  </div>
</div>
</div>
</div>
 Diapositiva 7.3: Fonti di dati 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Where IPD Lives</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number">1</div>
<div class="lesson-content">
<h4>Trialist Collaboration</h4>
<p>Direct contact with trial investigators. Build relationships. Offer co-authorship.</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number">2</div>
<div class="lesson-content">
<h4>Piattaforme di condivisione dei dati</h4>
<p>YODA Project, ClinicalStudyDataRequest.com, Vivli, ICPSR</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number">3</div>
<div class="lesson-content">
<h4>Regulatory Agencies</h4>
<p>EMA Policy 0070, FDA (limited), Health Canada</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number">4</div>
<div class="lesson-content">
<h4>Journal Requirements</h4>
<p>Many journals now require data sharing; check supplementary materials</p>
</div>
</div>
</div>
</div>
 Diapositiva 7.4: La collaborazione Lettera 
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">The Approach</div>
<div class="story-card animate delay-1">
<div class="place">HOW TO ASK</div>
<div class="narrative">
<strong>1. Inizia con la tua domanda</strong>‚Äîexplain why IPD is essential
                    <br/><br/>
<strong>2. Offer co-authorship</strong>‚Äîmake sharing worthwhile
                    <br/><br/>
<strong>3. Descrivere la sicurezza dei dati</strong>‚Äîhow you'll protect their patients
                    <br/><br/>
<strong>4. Fornire dizionari di dati</strong>‚Äîspecify exactly what you need
                    <br/><br/>
<strong>5. Set clear timelines</strong>‚Äîrespect their time
                  </div>
</div>
</div>
</div>
<!-- Slide 7.5: Missing IPD Problem -->
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">La trappola del bias di disponibilit√†</div>
<div class="simple-box animate delay-1">
<div class="simple-title">THE DANGER</div>
<div class="simple-text">
                    E se le sperimentazioni che <strong>share data</strong> sono sistematicamente diverse dalle sperimentazioni che <strong>don't share</strong>?
                    <br/><br/>
                    Industry trials: less likely to share<br/>
                    Negative trials: less likely to share<br/>
                    Older trials: data may be lost
                    <br/><br/>
<strong>Your IPD sample may be biased.</strong>
</div>
</div>
<div class="formula-box animate delay-2">
<div class="label">THE RULE</div>
<div class="formula">Always compare: IPD trials vs. non-IPD trials</div>
<div class="label">Do they differ in effect size, sample size, funding source?</div>
</div>
</div>
</div>
<!-- Slide 7.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "I dati esistono. La questione √® la fiducia.<br/>
                  Will they share what they have guarded?<br/>
                  Costruire il ponte con attenzione‚Äî<br/>
                  perch√© su quel ponte si incrociano i futuri dei pazienti."
                </div>
</div>
</div>
</div>
 ==================== MODULO 8: ARMONIZZAZIONE DEI DATI ==================== 
<div class="module-slides" data-module="8">
<!-- Slide 8.1: Opening -->
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  Hai raccolto il data<br/>
                  from twelve trials, five countries, three decades.<br/>
<br/>
                  But Trial A calls it <em>"cardiovascular death"</em><br/>
                  e la prova B lo chiama <em>"cardiac mortality"</em>.<br/>
<br/>
                  Sono la stessa cosa?
                </div>
</div>
</div>
 Diapositiva 8.2: La sfida dell'armonizzazione 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Il problema della Torre di Babele</div>
<div class="story-card animate delay-1">
<div class="place">EVERY IPD META-ANALYSIS</div>
<div class="narrative">
                    Trial from Japan: Age in years since 1900 (e.g., "54" = 1954 birth)<br/>
                    Trial from USA: Age in decimal years (e.g., 65.7)<br/>
                    Prova dal Regno Unito: Et√† ("65-74")<br/><br/>
                    Diabetes: HbA1c ‚â• 6.5% vs. fasting glucose ‚â• 126 vs. "physician diagnosis"<br/><br/>
                    Outcome: "Major adverse cardiac event" (one trial includes stroke, another doesn't)<br/><br/>
<strong>Prima dell'analisi: armonizzare tutto.</strong>
</div>
</div>
</div>
</div>
 Diapositiva 8.3: Il processo 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Il processo di armonizzazione</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number">1</div>
<div class="lesson-content">
<h4>Creare un dato principale Dizionario</h4>
<p>Define every variable you need: name, type, permitted values, derivation rules</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number">2</div>
<div class="lesson-content">
<h4>Map Each Trial's Variables</h4>
<p>Document how each trial's coding maps to your standardized definitions</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number">3</div>
<div class="lesson-content">
<h4>Verifica con i trialisti</h4>
<p>Verifica le tue interpretazioni. Conoscono i loro dati meglio di te.</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number">4</div>
<div class="lesson-content">
<h4>Validate Transformations</h4>
<p>Riproduci i risultati pubblicati dall'IPD. Se non corrispondono, indaga.</p>
</div>
</div>
</div>
</div>
<!-- Slide 8.4: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-harmonization">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">Il dilemma della definizione</span>
</div>
<div class="scenario-situation">
                    Stai armonizzando l'IPD da 8 studi sul diabete. L'outcome primario √® la "morte cardiovascolare".
                    <br/><br/>
                    Sei studi hanno utilizzato una definizione standard (codici ICD). Due studi degli anni '90 hanno utilizzato la "morte cardiaca valutata dallo sperimentatore" senza criteri standardizzati. Questi due studi mostrano effetti del trattamento pi√π ampi.
                  </div>
<div class="scenario-question">Come gestisci questo?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('harmonization', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">Includi tutti gli 8 studi: pi√π dati sono migliori e le definizioni sono "abbastanza vicine"</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('harmonization', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">Exclude the 2 non-standardized trials to maintain outcome consistency</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('harmonization', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">Analisi primaria con 6 studi coerenti; analisi di sensibilit√† aggiungendo gli altri 2</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-harmonization"></div>
</div>
</div>
</div>
 Diapositiva 8.5: La fase di convalida 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La validazione cruciale</div>
<div class="simple-box animate delay-1">
<div class="simple-title">THE TEST</div>
<div class="simple-text">
<strong>Prima di qualsiasi nuova analisi:</strong>
<br/><br/>
                    Riproduci i risultati pubblicati di ogni studio dall'IPD.
                    <br/><br/>
                    Se la tua analisi d√† RR = 0,78 ma la pubblicazione dice RR = 0,85,
                    <br/>
<strong>something is wrong.</strong>
<br/><br/>
                    Find the discrepancy. Fix it. Then proceed.
                  </div>
</div>
</div>
</div>
<!-- Slide 8.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "Different languages, different rulers,<br/>
                  different ways to name the same disease.<br/>
                  Prima di poter combinare, devi tradurre.<br/>
                  Prima di tradurre, devi capire."
                </div>
</div>
</div>
</div>
 ==================== MODULO 9: TEST DELLE INTERAZIONI ==================== 
<div class="module-slides" data-module="9">
<!-- Slide 9.1: Opening -->
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  Il trattamento funziona <em>on average</em>.<br/>
<br/>
                  Ma funziona allo stesso modo per i giovani e gli anziani?<br/>
                  Per quelli lievi e quelli gravi?<br/>
                  Per quello con il biomarcatore e quello senza?
                </div>
</div>
</div>
<!-- Slide 9.2: The Tamoxifen Discovery Revisited -->
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">L'interazione che √® cambiata Oncologia</div>
<div class="story-card animate delay-1">
<div class="place">EBCTCG, 1985-1998</div>
<div class="narrative">
                    The Early Breast Cancer Trialists' Group didn't just ask "Does tamoxifen work?"
                    <br/><br/>
                    They asked: <strong>"Does the effect differ by estrogen receptor status?"</strong>
<br/><br/>
                    L'interazione √® stata massiccia:
                    <br/><br/>
                    ER-positive: 47% reduction in recurrence<br/>
                    ER-negative: <strong>No benefit at all</strong>
</div>
<div class="source">EBCTCG. Lancet 1998;351:1451-67</div>
</div>
<div class="discovery-box animate delay-2">
<div class="insight">p<sub>interaction</sub> &lt; 0.00001</div>
<div class="label">The most important interaction in cancer medicine</div>
</div>
</div>
</div>
<!-- Slide 9.3: How to Test Interactions -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Testing Treatment-Covariate Interactions</div>
<div class="formula-box animate delay-1">
<div class="label">THE MODEL</div>
<div class="formula">Outcome = Œ≤<sub>1</sub>Treatment + Œ≤<sub>2</sub>Covariate + Œ≤<sub>3</sub>(Treatment √ó Covariate)</div>
<div class="label">Œ≤<sub>3</sub> is the interaction term - does treatment effect vary by covariate?</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">INTERPRETATION</div>
<div class="simple-text">
                    If Œ≤<sub>3</sub> is statistically significant:
                    <br/><br/>
                    L'effetto del trattamento <strong>differs</strong> between subgroups defined by the covariate.
                    <br/><br/>
                    In caso contrario: l'effetto del trattamento √® <strong>similar</strong> across subgroups
                    (or you lack power to detect a difference).
                  </div>
</div>
</div>
</div>
<!-- Slide 9.4: Within vs Between Study Interactions -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La distinzione critica</div>
<div class="compare-grid animate delay-1">
<div class="compare-box aggregate">
<h4>Between-Study Interaction</h4>
<ul>
<li>Compares trial-level averages</li>
<li>Ecological fallacy risk</li>
<li>Confounded by trial design</li>
<li>Low statistical power</li>
<li>Si pu√≤ fare con dati aggregati</li>
</ul>
</div>
<div class="compare-box ipd">
<h4>Within-Study Interaction</h4>
<ul>
<li>Compares patients within each trial</li>
<li>No ecological fallacy</li>
<li>Randomization preserved</li>
<li>Much higher power</li>
<li>Requires IPD</li>
</ul>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">LA CHIAVE INSIGHT</div>
<div class="simple-text">
                    IPD consente di testare <strong>within-study interactions</strong>,
                    where randomization ensures the comparison is fair.
                    <br/><br/>
                    Questo √® il gold standard per la modifica degli effetti.
                  </div>
</div>
</div>
</div>
<!-- Slide 9.5: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-interaction">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">La domanda sull'interazione dell'et√†</span>
</div>
<div class="scenario-situation">
                    La meta-analisi IPD dell'anticoagulazione per la fibrillazione atriale include 12.000 pazienti interazione e trovare p=0,03. I pazienti di et√† ‚â•75 anni mostrano un beneficio maggiore (RR 0,55) rispetto ai pazienti di et√† &lt;75 anni (RR 0,72).
                    <br/><br/>
                    Hai testato 8 potenziali modificatori dell'effetto nella tua analisi.
                  </div>
<div class="scenario-question">Come interpreti questo risultato?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('interaction', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">Riferisci che l'anticoagulazione funziona meglio nei pazienti pi√π anziani - l'interazione √® significativa</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('interaction', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">Apply multiple testing correction; with 8 tests, p=0.03 is likely a false positive</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('interaction', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">Report as hypothesis-generating, note the multiple comparisons, request external validation</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-interaction"></div>
</div>
</div>
</div>
<!-- Slide 9.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "La media nasconde l'interazione.<br/>
                  The interaction reveals who benefits.<br/>
                  Testare nell'ambito degli studi, non tra‚Äî<br/>
                  perch√© √® l√¨ che si trova la verit√†."
                </div>
</div>
</div>
</div>
 ==================== MODULO 10: PROGNOSI E PREVISIONE ==================== 
<div class="module-slides" data-module="10">
<!-- Slide 10.1: Opening -->
<div class="slide dark active">
<div class="content text-center">
<div class="rhetorical animate">
                  IPD non √® solo per i trattamenti.<br/>
<br/>
                  Quando si cerca <em>predict</em> who will die,<br/>
                  who will recover, who will relapse‚Äî<br/>
<em>l'individuo √® tutto</em>.
                </div>
</div>
</div>
 Slide 10.2: La storia di IMPACT 
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">Predicting Recovery After Brain Injury</div>
<div class="story-card animate delay-1">
<div class="place">IMPACT CONSORTIUM, 2005-PRESENT</div>
<div class="narrative">
                    Dopo una lesione cerebrale traumatica, le famiglie si pongono una domanda devastante:
                    <br/><br/>
<strong>"Will they ever wake up?"</strong>
<br/><br/>
                    Individual trials were too small to develop accurate prediction models.
                    <br/><br/>
                    IMPACT ha raccolto IPD da 11 studi, 9.205 pazienti e ha costruito un modello che prevede i risultati a 6 mesi dalle caratteristiche cliniche iniziali.
                  </div>
<div class="source">IMPACT Study Group. PLoS Med 2008;5:e165</div>
</div>
</div>
</div>
<!-- Slide 10.3: Why IPD for Prognosis -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Why Prognosis Demands IPD</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number">1</div>
<div class="lesson-content">
<h4>External Validation Across Populations</h4>
<p>Develop in some studies, validate in others. True test of generalizability.</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number">2</div>
<div class="lesson-content">
<h4>Non-linear Relationships</h4>
<p>Explore how predictors relate to outcome: linear? threshold? U-shaped?</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number">3</div>
<div class="lesson-content">
<h4>Multiple Predictor Interactions</h4>
<p>Age + GCS + pupil reactivity may interact in ways aggregate data cannot reveal</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number">4</div>
<div class="lesson-content">
<h4>Proper Handling of Missing Predictors</h4>
<p>Imputazione multipla a livello del paziente, non a livello di studio</p>
</div>
</div>
</div>
</div>
<!-- Slide 10.4: The TRIPOD+PRISMA-IPD Framework -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Reporting Standards</div>
<div class="compare-grid animate delay-1">
<div class="compare-box aggregate">
<h4>TRIPOD</h4>
<ul>
<li>Prediction model reporting</li>
<li>Sviluppo e validazione</li>
<li>Calibrazione e discriminazione</li>
<li>22 item checklist</li>
</ul>
</div>
<div class="compare-box ipd">
<h4>PRISMA-IPD</h4>
<ul>
<li>IPD meta-analysis reporting</li>
<li>Dettagli acquisizione dati</li>
<li>Harmonization process</li>
<li>Integrity checking</li>
</ul>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">PER MODELLI PROGNOSTIC IPD</div>
<div class="simple-text">
                    You need <strong>both</strong>: TREPPIEDE per il modello stesso, PRISMA-IPD per il processo di sintesi dei dati.
                  </div>
</div>
</div>
</div>
<!-- Slide 10.5: Clinical Impact -->
<div class="slide hope">
<div class="content text-center">
<div class="title green animate">When Prediction Saves Lives</div>
<div class="story-card animate delay-1">
<div class="place">L'IMPATTO CLINICO</div>
<div class="narrative">
                    The IMPACT model is now embedded in clinical decision support systems worldwide.
                    <br/><br/>
                    Quando arriva un paziente con una lesione cerebrale traumatica, il modello fornisce un <strong>probability of survival</strong>
                    and <strong>probability of favorable outcome</strong>.
                    <br/><br/>
                    Questo guida le conversazioni con le famiglie. Questo informa l'intensit√† del trattamento. Questo aiuta ad allocare le risorse di terapia intensiva.
                    <br/><br/>
<strong>Costruito da dati individuali. Al servizio dei singoli pazienti.</strong>
</div>
</div>
</div>
</div>
<!-- Slide 10.6: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain hope animate">
                  "To predict one patient's future,<br/>
                  devi imparare da migliaia di passato.<br/>
                  IPD racchiude queste storie‚Äî<br/>
                  each one a teacher, if you will listen."
                </div>
</div>
</div>
</div>
 ==================== MODULO 11: IL PARADOSSO DELL'ASPIRINA (ATT) ==================== 
<div class="module-slides" data-module="11">
<!-- Slide 11.1: Opening Sign -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non avete considerato la piccola tavoletta bianca<br/>
                  che √® stata data a <em>millions</em> per i loro cuori?<br/>
<br/>
                  Erano detto: <em>"Prendi questo e sarai protetto."</em><br/>
<br/>
                  But was every heart equally in need of protection?
                </div>
</div>
</div>
 Diapositiva 11.2: La storia del Premio Netflix 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La storia del Premio Netflix</div>
<div class="story-card animate delay-1">
<div class="place">A TRUE STORY</div>
<div class="narrative">
                    In 2006, Netflix released 100 million "anonymized" movie ratings for a $1 million prize.
                    <br/><br/>
                    Researchers quickly re-identified users by matching ratings with public IMDb reviews.
                    <br/><br/>
                    One lawsuit alleged a closeted lesbian was outed through her viewing patterns.
                    <br/><br/>
<strong>The lesson: removing names isn't anonymization.</strong>
<br/><br/>
                    IPD contiene sufficienti combinazioni di et√†, diagnosi, risposta al trattamento e date per identificare in modo univoco individui. La privacy richiede qualcosa di pi√π che eliminare la colonna del nome: richiede di comprendere come le combinazioni di dati diventano impronte digitali.
                  </div>
</div>
</div>
</div>
 Diapositiva 11.3: La collaborazione ATT 
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">Oxford, 2009</div>
<div class="story-card animate delay-1">
<div class="place">ANTITHROMBOTIC TRIALISTS' COLLABORATION</div>
<div class="narrative">
                    L'ATT ha raccolto dati individuali da <strong>95,000 patients</strong>
                    across 6 primary prevention trials of aspirin.
                    <br/><br/>
                    The published trials said: "Aspirin prevents heart attacks."
                    <br/><br/>
                    Ma l'ATT ha chiesto il proibito domanda:
                    <br/><br/>
<strong>"A quale costo? E per chi?"</strong>
</div>
<div class="source">ATT Collaboration. Lancet 2009;373:1849-60</div>
</div>
</div>
</div>
 Diapositiva 11.4: L'Apocalisse 
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">I numeri rivelati</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="border: 2px solid var(--green);">
<div class="stat-value" style="color:var(--green);">-12%</div>
<div class="stat-label">Heart Attacks Prevented</div>
</div>
<div class="stat-box" style="border: 2px solid var(--red);">
<div class="stat-value" style="color:var(--red);">+32%</div>
<div class="stat-label">Major Bleeds Caused</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">THE BALANCE</div>
<div class="simple-text">
                    For every <strong>1,000 low-risk patients</strong> prendendo l'aspirina per 5 anni:
                    <br/><br/>
<span style="color:var(--green);">2-3 heart attacks prevented</span><br/>
<span style="color:var(--red);">2-3 major bleeds caused</span>
<br/><br/>
<strong>I benefici e i danni si annullano.</strong>
</div>
</div>
</div>
</div>
 Diapositiva 11.5: L'albero decisionale 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La decisione basata sul rischio</div>
<div class="decision-tree animate delay-1">
<h4>Questo paziente dovrebbe assumere l'aspirina per la terapia primaria Prevenzione?</h4>
<div class="tree-level">
<div class="tree-node root">10-Year CVD Risk?</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 1rem;">
<div>
<div class="tree-node yes" style="background:rgba(34,197,94,0.3);">&gt;20%</div>
<div class="tree-label">High Risk</div>
</div>
<div>
<div class="tree-node question">10-20%</div>
<div class="tree-label">Intermediate</div>
</div>
<div>
<div class="tree-node no" style="background:rgba(197,48,48,0.3);">&lt;10%</div>
<div class="tree-label">Low Risk</div>
</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 1rem;">
<div class="tree-node action">Consider aspirin<br/>(benefit &gt; harm)</div>
<div class="tree-node aggregate">Shared decision<br/>(benefit ‚âà harm)</div>
<div class="tree-node" style="background:rgba(197,48,48,0.5);border-color:var(--red);">Avoid aspirin<br/>(harm &gt; benefit)</div>
</div>
</div>
</div>
</div>
<!-- Slide 11.6: Why Aggregate Failed -->
<div class="slide dark">
<div class="content text-center">
<div class="rhetorical animate">
                  Why did published meta-analyses miss this?
                </div>
<div class="simple-box animate delay-1">
<div class="simple-title">LA CECIT√Ä DEGLI AGGREGATI</div>
<div class="simple-text">
                    Published trials reported <strong>average benefits</strong>.
                    <br/><br/>
                    Non sono riusciti a dimostrare che i pazienti ad alto rischio hanno guadagnato<br/>
                    while low-risk patients lost.
                    <br/><br/>
                    Only by examining each patient's baseline risk,<br/>
                    each patient's outcomes,<br/>
                    could the <strong>interaction</strong> be revealed.
                  </div>
</div>
</div>
</div>
<!-- Slide 11.7: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-aspirin">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">Il dilemma della prevenzione primaria</span>
</div>
<div class="scenario-situation">
                    Un uomo di 52 anni chiede informazioni sull'aspirina per la prevenzione dell'infarto. Non ha precedenti di malattie cardiovascolari, il colesterolo √® al limite, la pressione arteriosa √® controllata, non √® un fumatore. Il suo rischio di malattie cardiovascolari a 10 anni √® dell'8%.
                    <br/><br/>
                    Ha letto online che "l'aspirina previene gli attacchi di cuore" e vuole il tuo consiglio.
                  </div>
<div class="scenario-question">Cosa gli dici?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('aspirin', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">"Yes, take aspirin daily - it's proven to prevent heart attacks"</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('aspirin', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">"At your risk level, aspirin's bleeding risk roughly equals its heart benefit - I'd recommend against it"</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('aspirin', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">"Take baby aspirin - the lower dose is safer"</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-aspirin"></div>
</div>
</div>
</div>
<!-- Slide 11.8: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "La medicina che salva le persone in pericolo<br/>
                  pu√≤ nuocere sicuro.<br/>
<br/>
                  Conosci il rischio del tuo paziente prima di prescrivere.<br/>
                  Questo √® ci√≤ che ci hanno insegnato i dati individuali."
                </div>
<div class="gold-line animate delay-2"></div>
<p class="animate delay-3" style="color:rgba(255,255,255,0.6);font-style:italic;">
                  95,000 patients. One truth: risk determines benefit.
                </p>
</div>
</div>
</div>
 ==================== MODULO 12: LA RIVELAZIONE DELLA PRESSIONE SANGUIGNA (BPLTTC) ==================== 
<div class="module-slides" data-module="12">
<!-- Slide 12.1: Opening -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai visto come si dibatteva per decenni:<br/>
<em>"I vecchi dovrebbero essere trattati allo stesso modo dei giovani?"</em><br/>
<br/>
                  Some said: "Lower is always better."<br/>
                  Altri dicevano: "I vecchi sono fragili. Sii prudente."<br/>
<br/>
                  Chi aveva ragione?
                </div>
</div>
</div>
 Diapositiva 12.2: Il dibattito 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La controversia sulla curva J</div>
<div class="story-card animate delay-1">
<div class="place">CARDIOLOGY CONFERENCES, 1980s-2000s</div>
<div class="narrative">
                    Per anni, i medici hanno sostenuto:
                    <br/><br/>
<strong>Il campo aggressivo:</strong> "Every mmHg of BP reduction saves lives.<br/>
                    Treat everyone to target 120/80."
                    <br/><br/>
<strong>Il campo conservatore Campo:</strong> "In the elderly, low BP causes falls, strokes, death.<br/>
                    There's a J-curve‚Äîtoo low is dangerous."
                    <br/><br/>
                    Individual trials were too small to settle it.
                    <strong>Fino a quando il BPLTTC ha raccolto i dati individuali.</strong>
</div>
</div>
</div>
</div>
 Diapositiva 12.3: La collaborazione 
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">The Blood Pressure Lowering Treatment Trialists</div>
<div class="stats-grid animate delay-1">
<div class="stat-box">
<div class="stat-value" style="color:var(--blue);">48</div>
<div class="stat-label">Trials Combined</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--gold);">344,716</div>
<div class="stat-label">Individual Patients</div>
</div>
<div class="stat-box">
<div class="stat-value" style="color:var(--teal);">15+</div>
<div class="stat-label">Years of Follow-up</div>
</div>
</div>
<div class="simple-box blue animate delay-2">
<div class="simple-title">THE QUESTION</div>
<div class="simple-text">
                    Does the benefit of BP lowering vary by age?
                    <br/>
                    Is there a J-curve at very low pressures?
                    <br/>
                    Do the very old (&gt;80 years) still benefit?
                  </div>
</div>
<div class="source animate delay-3" style="color:rgba(255,255,255,0.5);font-size:0.8rem;margin-top:1rem;">
                  BPLTTC. Lancet 2021;397:1625-36
                </div>
</div>
</div>
 Diapositiva 12.4: La risposta 
<div class="slide hope">
<div class="content text-center">
<div class="title green animate">La risposta, a Ultima</div>
<div class="discovery-box animate delay-1">
<div class="insight">Benefit at Every Age</div>
<div class="label">La riduzione proporzionale del rischio √® stata costante dai 55 agli 85 anni+</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">WHAT IPD SHOWED</div>
<div class="simple-text">
<strong>Every 5 mmHg BP reduction:</strong>
<br/><br/>
                    Age 55-64: 10% lower major CV events<br/>
                    Age 65-74: 10% lower major CV events<br/>
                    Age 75-84: 10% lower major CV events<br/>
                    Age ‚â•85: <strong>Still 10% lower</strong>
<br/><br/>
<em>p</em><sub>interaction</sub> = 0,85. Nessuna prova di modificazione dell'et√†.
                  </div>
</div>
</div>
</div>
 Diapositiva 12.5: Il mito della curva J 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">E la curva J?</div>
<div class="story-card animate delay-1">
<div class="place">THE RESOLUTION</div>
<div class="narrative">
                    Il BPLTTC ha testato una curva J esaminando i pazienti<br/>
                    who achieved very low blood pressures.
                    <br/><br/>
<strong>Result:</strong> No J-curve in randomized comparisons.
                    <br/><br/>
                    L'apparente curva J nei dati osservazionali era <em>reverse causation</em>‚Äî
                    sick patients have low BP because they're sick,
                    not sick because their BP is low.
                    <br/><br/>
<strong>Solo l'IPD degli RCT poteva districare questo problema.</strong>
</div>
</div>
</div>
</div>
<!-- Slide 12.6: Decision Tree -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Treating Hypertension by Age</div>
<div class="decision-tree animate delay-1">
<h4>Should This Elderly Patient Get BP Treatment?</h4>
<div class="tree-level">
<div class="tree-node root">Patient Age?</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 2rem;">
<div class="tree-node yes" style="min-width:80px;">55-74</div>
<div class="tree-node yes" style="min-width:80px;">75-84</div>
<div class="tree-node yes" style="min-width:80px;">85+</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level">
<div class="tree-node action" style="background:var(--green);min-width:300px;">
                      Treat if BP elevated<br/>
<span style="font-size:0.75rem;">Proportional benefit maintained across all ages</span>
</div>
</div>
</div>
<div class="simple-box animate delay-2" style="margin-top:1.5rem;">
<div class="simple-title">THE LESSON</div>
<div class="simple-text">
                    Age alone is not a reason to withhold treatment.
                    <br/>
                    Consider frailty, life expectancy, patient preference‚Äîbut not age.
                  </div>
</div>
</div>
</div>
<!-- Slide 12.7: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-elderly-bp">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">La pressione sanguigna di una persona di 82 anni</span>
</div>
<div class="scenario-situation">
                    Una donna di 82 anni ha una pressione arteriosa di 158/88. √à indipendente, cognitivamente intatta e non ha precedenti di cadute. Un collega dice: "√à troppo vecchia per un trattamento aggressivo per la pressione arteriosa. La curva a J, lo sai."
                    <br/><br/>
                    Ricordi la meta-analisi BPLTTC IPD.
                  </div>
<div class="scenario-question">What do you do?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('elderly-bp', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">D'accordo con il tuo collega: accetta obiettivi di pressione arteriosa pi√π elevati per gli anziani</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('elderly-bp', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">Cita l'evidenza BPLTTC che il beneficio continua negli anziani e iniziare il trattamento</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('elderly-bp', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">Wait for a cardiovascular event before treating</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-elderly-bp"></div>
</div>
</div>
</div>
<!-- Slide 12.8: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain hope animate">
                  "Dicevano che gli anziani erano troppo fragili per le medicine.<br/>
                  Ma i dati individuali mostravano il contrario:<br/>
<br/>
                  At every age, the benefit endures.<br/>
                  Do not let age alone deny protection."
                </div>
</div>
</div>
</div>
 ==================== MODULO 13: LA FINESTRA DEL TEMPO DI CORSA ==================== 
<div class="module-slides" data-module="13">
<!-- Slide 13.1: Opening Sign -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai assistito alla corsa contro il tempo<br/>
                  when a clot blocks the brain?<br/>
<br/>
                  Every minute, <em>two million neurons die</em>.<br/>
<br/>
                  But when does the window close?<br/>
                  When is it too late to intervene?
                </div>
</div>
</div>
 Diapositiva 13.2: La posta in gioco 
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">Time Is Brain</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="border: 2px solid var(--red);">
<div class="stat-value" style="color:var(--red);">1.9M</div>
<div class="stat-label">Neurons Lost Per Minute</div>
</div>
<div class="stat-box" style="border: 2px solid var(--orange);">
<div class="stat-value" style="color:var(--orange);">14B</div>
<div class="stat-label">Synapses Lost Per Minute</div>
</div>
</div>
<div class="story-card animate delay-2">
<div class="place">THE QUESTION</div>
<div class="narrative">
                    La trombolisi pu√≤ sciogliere il coagulo e ripristinare il sangue flusso.
                    <br/><br/>
                    But given too late, it causes bleeding into dying brain tissue.
                    <br/><br/>
<strong>What is the time window? 3 hours? 4.5 hours? 6 hours?</strong>
<br/><br/>
                    Individual trials disagreed. Guidelines were uncertain.
                  </div>
</div>
</div>
</div>
 Diapositiva 13.3: La soluzione IPD 
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">Gli sperimentatori della trombolisi da ictus</div>
<div class="story-card animate delay-1">
<div class="place">STT COLLABORATIVE GROUP, 2014</div>
<div class="narrative">
                    L'STT ha raccolto dati individuali da <strong>6,756 patients</strong>
                    across 9 major alteplase trials.
                    <br/><br/>
                    They knew <em>exactly</em> when each patient's stroke began.
                    They knew <em>exactly</em> when thrombolysis was given.
                    They knew <em>exactly</em> who lived, who died, who recovered.
                    <br/><br/>
<strong>They could map benefit against time, minute by minute.</strong>
</div>
<div class="source">STT Collaborative Group. Lancet 2014;384:1929-35</div>
</div>
</div>
</div>
 Diapositiva 13.4: Il tempo Curva 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La finestra di dissolvenza</div>
<div class="stats-grid animate delay-1">
<div class="stat-box" style="border: 2px solid var(--green);">
<div class="stat-value" style="color:var(--green);">0-3h</div>
<div class="stat-label">O 1,75 per un buon risultato</div>
</div>
<div class="stat-box" style="border: 2px solid var(--teal);">
<div class="stat-value" style="color:var(--teal);">3-4.5h</div>
<div class="stat-label">O 1,26 per un buon risultato</div>
</div>
<div class="stat-box" style="border: 2px solid var(--orange);">
<div class="stat-value" style="color:var(--orange);">4.5-6h</div>
<div class="stat-label">OR 1.15 (not significant)</div>
</div>
</div>
<div class="simple-box animate delay-2">
<div class="simple-title">IL DECADIMENTO DEI BENEFICI</div>
<div class="simple-text">
                    Every 15 minutes of delay reduced the benefit.
                    <br/><br/>
                    Treated at 90 min: <strong>1 in 4</strong> achieve excellent outcome<br/>
                    Treated at 180 min: <strong>1 in 7</strong> achieve excellent outcome<br/>
                    Treated at 270 min: <strong>1 in 14</strong> achieve excellent outcome
                  </div>
</div>
</div>
</div>
<!-- Slide 13.5: Decision Tree -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La trombolisi Decisione</div>
<div class="decision-tree animate delay-1">
<h4>Acute Ischemic Stroke: Give Thrombolysis?</h4>
<div class="tree-level">
<div class="tree-node root">Time Since Symptom Onset?</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 0.75rem;">
<div>
<div class="tree-node yes" style="background:rgba(34,197,94,0.5);min-width:90px;">0-3h</div>
<div class="tree-label">Strong benefit</div>
</div>
<div>
<div class="tree-node yes" style="background:rgba(0,212,170,0.4);min-width:90px;">3-4.5h</div>
<div class="tree-label">Moderate benefit</div>
</div>
<div>
<div class="tree-node question" style="min-width:90px;">4.5-6h</div>
<div class="tree-label">Uncertain</div>
</div>
<div>
<div class="tree-node no" style="background:rgba(197,48,48,0.5);min-width:90px;">&gt;6h</div>
<div class="tree-label">Harm likely</div>
</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 0.75rem;">
<div class="tree-node action" style="font-size:0.7rem;padding:0.5rem;">TREAT<br/>URGENTLY</div>
<div class="tree-node action" style="font-size:0.7rem;padding:0.5rem;">TREAT<br/>if eligible</div>
<div class="tree-node aggregate" style="font-size:0.7rem;padding:0.5rem;">Consider<br/>imaging</div>
<div class="tree-node" style="background:rgba(197,48,48,0.5);font-size:0.7rem;padding:0.5rem;">Generally<br/>avoid</div>
</div>
</div>
</div>
</div>
 Diapositiva 13.6: Perch√© AD non ha potuto rispondere 
<div class="slide dark">
<div class="content text-center">
<div class="rhetorical animate">
                  Why did we need individual data?
                </div>
<div class="simple-box animate delay-1">
<div class="simple-title">LA LIMITAZIONE DELLE MEDIE</div>
<div class="simple-text">
                    Trial A: "Patients treated within 3 hours" (average: 2.1 hours)<br/>
                    Trial B: "Patients treated within 6 hours" (average: 4.2 hours)
                    <br/><br/>
                    These <em>overlapping, inconsistent windows</em> couldn't be compared.
                    <br/><br/>
                    Only by knowing <strong>each patient's exact time</strong><br/>
                    could the continuous decay of benefit be mapped.
                  </div>
</div>
</div>
</div>
<!-- Slide 13.7: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-stroke">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">L'ictus a 4 ore</span>
</div>
<div class="scenario-situation">
                    Un uomo di 68 anni presenta un ictus acuto 4 ore fa. La TC non mostra emorragia, il punteggio NIHSS √® 12 (moderato). La famiglia chiede: "√à troppo tardi per il farmaco anti-coagulazione?"
                    <br/><br/>
                    Door-to-needle time will add 30 minutes, making total time ~4.5 hours.
                  </div>
<div class="scenario-question">What do you do?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('stroke', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">"It's too late - the 3-hour window has passed"</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('stroke', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">"Siamo ancora entro la finestra di 4,5 ore - procedere urgentemente con la trombolisi"</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('stroke', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">"Wait for MRI to see if there's salvageable tissue"</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-stroke"></div>
</div>
</div>
</div>
<!-- Slide 13.8: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "Every minute the clot remains,<br/>
                  two million neurons perish.<br/>
<br/>
                  L'IPD ci ha mostrato la finestra in dissolvenza.<br/>
                  Act quickly, or the window closes forever."
                </div>
</div>
</div>
</div>
 ==================== MODULO 14: DATI MANCANTI NELL'IPD ==================== 
<div class="module-slides" data-module="14">
<!-- Slide 14.1: Opening -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Hai raccolto i dati individuali.<br/>
                  Apri i file con speranza.<br/>
<br/>
                  E poi vedi: <em>empty cells</em>.<br/>
<br/>
                  Age: 67. Sex: Male. Smoking status: <em>missing</em>.<br/>
                  Outcome at 1 year: <em>missing</em>.<br/>
<br/>
                  What now?
                </div>
</div>
</div>
 Diapositiva 14.2: I tre tipi 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">I tre tipi di Mancanza</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number" style="background:var(--green);">1</div>
<div class="lesson-content">
<h4>Missing Completely at Random (MCAR)</h4>
<p>Lab machine broke randomly. No relation to patient characteristics. <strong>Safe to ignore (but wasteful).</strong></p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number" style="background:var(--orange);">2</div>
<div class="lesson-content">
<h4>Missing at Random (MAR)</h4>
<p>Older patients more likely to miss follow-up. Missingness related to <em>observed</em> variables. <strong>Imputation can help.</strong></p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number" style="background:var(--red);">3</div>
<div class="lesson-content">
<h4>Mancante non casuale (MNAR)</h4>
<p>I pazienti con risultati scadenti abbandonano. Mancanza relativa al <em>missing value itself</em>. <strong>Pericoloso. Richiede un'analisi di sensibilit√†.</strong></p>
</div>
</div>
</div>
</div>
 Diapositiva 14.3: L'albero decisionale 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Gestione dei dati mancanti</div>
<div class="decision-tree animate delay-1">
<h4>Cosa fare con i valori mancanti?</h4>
<div class="tree-level">
<div class="tree-node root">How much is missing?</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 1.5rem;">
<div>
<div class="tree-node yes" style="background:rgba(34,197,94,0.3);">&lt;5%</div>
<div class="tree-label">Minor</div>
</div>
<div>
<div class="tree-node question">5-20%</div>
<div class="tree-label">Moderate</div>
</div>
<div>
<div class="tree-node no" style="background:rgba(197,48,48,0.3);">&gt;20%</div>
<div class="tree-label">Substantial</div>
</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 1.5rem;">
<div class="tree-node action" style="font-size:0.75rem;">Complete case<br/>may suffice</div>
<div class="tree-node ipd" style="font-size:0.75rem;">Multiple<br/>imputation</div>
<div class="tree-node aggregate" style="font-size:0.75rem;">Impute +<br/>sensitivity</div>
</div>
</div>
</div>
</div>
<!-- Slide 14.4: Multiple Imputation -->
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">Imputazione multipla: la Standard</div>
<div class="formula-box animate delay-1">
<div class="label">THE PROCESS</div>
<div class="formula">1. Impute ‚Üí 2. Analyze ‚Üí 3. Pool</div>
<div class="label">Create M imputed datasets, analyze each, combine using Rubin's rules</div>
</div>
<div class="simple-box blue animate delay-2">
<div class="simple-title">WHY MULTIPLE?</div>
<div class="simple-text">
                    L'imputazione singola presuppone che tu conosca il valore mancante.
                    <br/><br/>
                    Multiple imputation (M=20-50 datasets) reflects <strong>uncertainty</strong>
                    su quale potrebbe essere stato il valore mancante.
                    <br/><br/>
                    Ci√≤ preserva errori standard e valori p validi.
                  </div>
</div>
</div>
</div>
<!-- Slide 14.5: IPD-Specific Issues -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Dati mancanti specifici di IPD Sfide</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number">1</div>
<div class="lesson-content">
<h4>Systematically Missing Variables</h4>
<p>Trial A measured biomarker X. Trial B didn't. Can't impute what was never collected.</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number">2</div>
<div class="lesson-content">
<h4>Multilevel Structure</h4>
<p>Patients nested within trials. Imputation model must account for clustering.</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number">3</div>
<div class="lesson-content">
<h4>Different Follow-up Durations</h4>
<p>Prova A seguita per 2 anni. Prova B per 5 anni. L'analisi della sopravvivenza ha bisogno di cure.</p>
</div>
</div>
</div>
</div>
<!-- Slide 14.6: Decision Tree for Systematically Missing -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">When a Variable Is Missing Entirely</div>
<div class="decision-tree animate delay-1">
<h4>Trial Didn't Collect Your Key Covariate</h4>
<div class="tree-level">
<div class="tree-node root">Is it an effect modifier or confounder?</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 2rem;">
<div>
<div class="tree-node question">Effect Modifier</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-node aggregate" style="font-size:0.75rem;">Restrict interaction<br/>analysis to trials<br/>con la variabile</div>
</div>
<div>
<div class="tree-node question">Confounder</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-node ipd" style="font-size:0.75rem;">Sensitivity analysis<br/>varying assumptions<br/>about unmeasured</div>
</div>
</div>
</div>
</div>
</div>
<!-- Slide 14.7: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-missing">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">Il biomarcatore mancante</span>
</div>
<div class="scenario-situation">
                    Il tuo IPD-MA verifica se un nuovo farmaco antitumorale funziona meglio nei pazienti positivi al biomarcatore. Hai IPD da 8 prove. Ma 3 studi (40% dei pazienti) non hanno misurato affatto il biomarcatore.
                    <br/><br/>
                    Questi 3 studi tendono ad essere pi√π vecchi e pi√π piccoli.
                  </div>
<div class="scenario-question">Come si analizza l'interazione?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('missing', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">Impute the biomarker status based on other patient characteristics</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('missing', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">Analizzare l'interazione solo nei 5 studi con dati sui biomarcatori; analisi di sensibilit√† comprendente tutte le prove per l'effetto complessivo</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('missing', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">Escludere interamente le 3 prove dalla meta-analisi</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-missing"></div>
</div>
</div>
</div>
<!-- Slide 14.8: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain animate">
                  "La cella vuota non √® nulla.<br/>
                  It is a question: <em>Perch√© questo √® sconosciuto?</em><br/>
<br/>
                  Rispondi a questa domanda prima di riempire la gap‚Äî<br/>
                  per il motivo dell'assenza modella la soluzione."
                </div>
</div>
</div>
</div>
 ==================== MODULO 15: LA TRAPPOLA DELLA DISPONIBILIT√Ä ==================== 
<div class="module-slides" data-module="15">
<!-- Slide 15.1: Opening -->
<div class="slide black active">
<div class="content text-center">
<div class="rhetorical animate">
                  Non hai visto il ricercatore<br/>
                  che ha raccolto dati <em>willing</em> trialists<br/>
                  e ha dichiarato la vittoria?<br/>
<br/>
                  But the <em>unwilling</em> held secrets.<br/>
                  E quei segreti hanno cambiato tutto.
                </div>
</div>
</div>
 Diapositiva 15.2: La storia del Tamiflu 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La storia di Tamiflu</div>
<div class="story-card animate delay-1">
<div class="place">A TRUE STORY</div>
<div class="narrative">
                    Per anni, i governi hanno accumulato scorte di Tamiflu per l'influenza pandemica, spendendo miliardi.
                    <br/><br/>
                    Cochrane reviewers requested trial data to verify efficacy. Roche refused, citing confidentiality.
                    <br/><br/>
                    Per cinque anni, il BMJ ha condotto una campagna per la trasparenza. Quando i rapporti completi sugli studi clinici furono finalmente pubblicati nel 2014, il quadro cambi√≤: il Tamiflu ridusse la durata dei sintomi di meno di un giorno e non prevenne le complicanze.
                    <br/><br/>
<strong>Miliardi spesi per un farmaco le cui prove complete erano tenute nascoste.</strong>
<br/><br/>
                    La saga del Tamiflu ha trasformato le aspettative: oggi, la trasparenza degli studi clinici sta diventando la norma, non l'eccezione.
                  </div>
</div>
</div>
</div>
 Diapositiva 15.3: Le prove 
<div class="slide blood">
<div class="content text-center">
<div class="title red animate">When IPD Is Selectively Available</div>
<div class="simple-box animate delay-1">
<div class="simple-title">I RISULTATI EMPIRICI</div>
<div class="simple-text">
                    Gli studi hanno confrontato gli studi che condividono l'IPD con quelli che condividono l'IPD non:
                    <br/><br/>
<strong>Industry-sponsored trials:</strong> Less likely to share<br/>
<strong>Prove con risultati negativi:</strong> Less likely to share<br/>
<strong>Older trials:</strong> Dati spesso persi
                    <br/><br/>
                    If these trials systematically differ in effect size,<br/>
<strong>il tuo IPD-MA √® distorto.</strong>
</div>
</div>
<div class="source animate delay-2" style="color:rgba(255,255,255,0.5);font-size:0.8rem;margin-top:1rem;">
                  Ahmed I, et al. BMJ 2012;344:d7762
                </div>
</div>
</div>
 Diapositiva 15.4: Il Confronto 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">Always Compare: IPD vs. Non-IPD Trials</div>
<div class="decision-tree animate delay-1">
<h4>Assessing Availability Bias</h4>
<div class="tree-level">
<div class="tree-node root">Compare AD effects: trials with IPD vs. without</div>
</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-level" style="gap: 2rem;">
<div>
<div class="tree-node yes">Similar Effects</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-node action" style="font-size:0.75rem;">Low concern<br/>for bias</div>
</div>
<div>
<div class="tree-node no">Different Effects</div>
<div class="tree-arrow">‚Üì</div>
<div class="tree-node" style="background:rgba(197,48,48,0.5);font-size:0.75rem;">High concern<br/>Analisi di sensibilit√† necessaria</div>
</div>
</div>
</div>
</div>
</div>
 Diapositiva 15.5: La lista di controllo 
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">La lista di controllo del bias di disponibilit√†</div>
<div class="lesson-item animate delay-1">
<div class="lesson-number" style="background:var(--green);">‚úì</div>
<div class="lesson-content">
<h4>Report IPD retrieval rate</h4>
<p>"Abbiamo ottenuto IPD da 12/15 prove (80%)"</p>
</div>
</div>
<div class="lesson-item animate delay-2">
<div class="lesson-number" style="background:var(--green);">‚úì</div>
<div class="lesson-content">
<h4>Compare IPD vs. non-IPD trial characteristics</h4>
<p>Dimensione del campione, finanziamento, data di pubblicazione, dimensione dell'effetto dai dati aggregati</p>
</div>
</div>
<div class="lesson-item animate delay-3">
<div class="lesson-number" style="background:var(--green);">‚úì</div>
<div class="lesson-content">
<h4>Sensitivity analysis including non-IPD trials</h4>
<p>Analisi in due fasi che combina IPD + AD da studi senza condivisione</p>
</div>
</div>
<div class="lesson-item animate delay-4">
<div class="lesson-number" style="background:var(--green);">‚úì</div>
<div class="lesson-content">
<h4>Discutere le ragioni della non condivisione</h4>
<p>Data lost? Refused? Never requested? Each has different implications.</p>
</div>
</div>
</div>
</div>
<!-- Slide 15.6: Branching Scenario -->
<div class="slide gradient">
<div class="content text-center">
<div class="scenario-panel animate" id="scenario-availability">
<div class="scenario-header">
<span class="scenario-icon">üîÄ</span>
<span class="scenario-title">Il riluttante Sperimentatori</span>
</div>
<div class="scenario-situation">
                    Il tuo IPD-MA di un intervento chirurgico ha ottenuto dati da 8 dei 12 studi ammissibili (67%). I 4 studi di non condivisione sono tutti finanziati dall'industria e mostrano benefici minori nelle loro pubblicazioni (OR aggregato 0,95) rispetto agli 8 studi IPD (OR aggregato 0,72).
                    <br/><br/>
                    La tua analisi IPD mostra OR 0,70.
                  </div>
<div class="scenario-question">Come riporti questo?</div>
<div class="scenario-choices">
<div class="scenario-choice" onclick="selectScenarioChoice('availability', 'a')">
<span class="choice-letter">A</span>
<span class="choice-text">Report IPD result (OR 0.70) as the main finding - IPD is gold standard</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('availability', 'b')">
<span class="choice-letter">B</span>
<span class="choice-text">Riportare il risultato IPD con un avvertimento evidente sul bias di disponibilit√† e sull'analisi della sensibilit√†, incluso l'AD da studi senza condivisione</span>
</div>
<div class="scenario-choice" onclick="selectScenarioChoice('availability', 'c')">
<span class="choice-letter">C</span>
<span class="choice-text">Wait until you get 100% IPD before publishing</span>
</div>
</div>
<div class="scenario-consequence" id="consequence-availability"></div>
</div>
</div>
</div>
 Diapositiva 15.7: L'approccio combinato 
<div class="slide ipd">
<div class="content text-center">
<div class="title blue animate">La soluzione ibrida in due fasi</div>
<div class="formula-box animate delay-1">
<div class="label">COMBINING IPD + AD</div>
<div class="formula">Stage 1: Analyze IPD trials ‚Üí get Œ∏<sub>IPD</sub></div>
<div class="formula">Stage 2: Meta-analyze Œ∏<sub>IPD</sub> + Œ∏<sub>AD</sub> da non IPD prove</div>
<div class="label">Uses all available evidence, even when IPD incomplete</div>
</div>
<div class="simple-box blue animate delay-2">
<div class="simple-title">THE PRINCIPLE</div>
<div class="simple-text">
<strong>IPD non √® tutto o niente.</strong>
<br/><br/>
                    Utilizza IPD dove disponibile (per test di interazione).<br/>
                    Supplemento con AD per la stima dell'effetto complessivo.<br/>
                    Trasparenza su ci√≤ che deriva dove.
                  </div>
</div>
</div>
</div>
<!-- Slide 15.8: Refrain -->
<div class="slide black">
<div class="content text-center">
<div class="refrain warning animate">
                  "Il volere potrebbe non rappresentare il tutto.<br/>
                  Le porte aperte potrebbero nascondere la verit√† dietro quelle chiuse.<br/>
<br/>
                  Always ask: Who refused to share?<br/>
                  And what might they be hiding?"
                </div>
</div>
</div>
</div>
 ==================== MODULO 16: QUIZ E RIFERIMENTI ==================== 
<div class="module-slides" data-module="16">
<!-- Slide 11.1: Quiz 1 -->
<div class="slide dark active">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">Che cosa ha scoperto l'Early Breast Cancer Trialists' Group che i singoli studi non potevano?</div>
<div class="quiz-options">
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Tamoxifen works better than placebo</div>
<div class="quiz-option" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Tamoxifen only works in estrogen receptor positive tumors</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Tamoxifen has significant side effects</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Tamoxifen works better in younger women</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<!-- Slide 11.2: Quiz 2 -->
<div class="slide dark">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">What is the "ecological fallacy" in meta-analysis?</div>
<div class="quiz-options">
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Assuming environmental factors don't affect treatment</div>
<div class="quiz-option" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Assuming between-study relationships apply to within-study (individual) relationships</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Mettendo in comune studi provenienti da diverse regioni ecologiche</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Using outdated trials in modern meta-analyses</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<!-- Slide 11.3: Quiz 3 -->
<div class="slide dark">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">Quando √® preferibile un'analisi IPD a una fase rispetto a in due fasi?</div>
<div class="quiz-options">
<div class="quiz-option" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">When trials have sparse events or rare outcomes</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">When you have many large trials</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">When you want to create forest plots</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Quando i risultati sono comuni e il follow-up √® breve</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<!-- Slide 11.4: Quiz 4 -->
<div class="slide dark">
<div class="content text-center">
<div class="quiz-container animate">
<div class="quiz-question">Cosa si dovrebbe fare prima di analizzare l'IPD da pi√π studi?</div>
<div class="quiz-options">
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Raggruppare immediatamente tutti i dati ed eseguire l'analisi principale</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Exclude trials with missing variables</div>
<div class="quiz-option" onclick="checkAnswer(this, true)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Riprodurre i risultati pubblicati di ogni studio dall'IPD per verificare integrit√† dei dati</div>
<div class="quiz-option" onclick="checkAnswer(this, false)" onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();this.click();}" role="button" tabindex="0">Convert all continuous variables to categorical</div>
</div>
<div class="quiz-feedback"></div>
</div>
</div>
</div>
<!-- Slide 11.5: References -->
<div class="slide dark">
<div class="content text-center">
<div class="title gold animate">References</div>
<div class="references animate delay-1">
<h4>Fonti chiave citate in questo Corso</h4>
<ol>
<li>Riley RD, et al. <span class="journal">Meta-analisi dei dati dei singoli partecipanti: un manuale per la ricerca sanitaria.</span> Wiley, 2021.</li>
<li>Stewart LA, et al PRISMA-IPD: Elementi di reporting preferiti per revisioni sistematiche e meta-analisi dei dati dei singoli partecipanti. <span class="journal">JAMA</span> 2015;313:1657-65.</li>
<li>Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. <span class="journal">Cochrane Database Syst Rev</span> 2001.</li>
<li>Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of LDL-lowering therapy. <span class="journal">Lancet</span> 2010;376:1670-81.</li>
<li>Roberts D, et al. Antenatal corticosteroids for accelerating fetal lung maturation. <span class="journal">Cochrane Database Syst Rev</span> 2017.</li>
<li>IMPACT Study Group. Predicting outcome after traumatic brain injury. <span class="journal">PLoS Med</span> 2008;5:e165.</li>
<li>Debray TPA, et al. Get real in individual participant data meta-analysis. <span class="journal">Int J Epidemiol</span> 2015;44:1287-97.</li>
<li>Burke DL, et al. Meta-analysis using individual participant data. <span class="journal">Stat Med</span> 2017;36:320-38.</li>
</ol>
</div>
</div>
</div>
<!-- Slide 11.6: Completion -->
<div class="slide hope">
<div class="content text-center">
<div class="big-number green animate" style="font-size:5rem;">‚úî</div>
<div class="title green animate delay-1">Course Complete</div>
<div class="gold-line animate delay-2"></div>
<div class="refrain hope animate delay-3">
                  "Nell'aggregato, i singoli pazienti scompare.<br/>
                  But you have learned to find them.<br/>
                  You have learned to ask: Who benefits? Who is harmed?<br/>
<br/>
                  Ora vai e non lasciare che nessun paziente scompaia nel mondo media."
                </div>
<p class="animate delay-4" style="color:var(--gold);font-family:'Cormorant Garamond',serif;font-size:1.2rem;margin-top:1.5rem;">
                  Il paziente nascosto: ora li vedi.
                </p>
<button aria-label="Ottieni il certificato di completamento" class="btn primary animate delay-5" onclick="showCertificate()" style="margin-top:2rem;padding:1rem 2rem;font-size:1.1rem;">
                  üéì Ottieni il tuo certificato
                </button>
</div>
</div>
</div>
<!-- Navigation -->
<nav aria-label="Slide navigation" class="slide-nav" role="navigation">
<button aria-label="Previous slide" class="nav-btn" onclick="prevSlide()" title="Previous slide (Left arrow)">‚Üê</button>
<div class="nav-center">
<div aria-atomic="true" aria-live="polite" class="slide-counter" id="slideCounter">1 / 6</div>
<div aria-label="Slide indicators" class="progress" id="progressDots" role="tablist"></div>
</div>
<button aria-label="Next slide" class="nav-btn" onclick="nextSlide()" title="Next slide (Right arrow or Space)">‚Üí</button>
</nav>
</div>
</div>
</main>
</div>
<script>
    function toggleSidebar() {
      document.querySelector('.sidebar').classList.toggle('open');
      var overlay = document.querySelector('.sidebar-overlay');
      if (overlay) overlay.classList.toggle('show');
      var btn = document.querySelector('.mobile-menu-toggle, .sidebar-toggle, .hamburger');
      if (btn) btn.setAttribute('aria-expanded', btn.getAttribute('aria-expanded') === 'true' ? 'false' : 'true');
    }

    const modules = [
      { id: 1, title: "The Vanishing", subtitle: "Why IPD matters", slides: 6 },
      { id: 2, title: "Aggregate vs IPD", subtitle: "L'errore ecologico", slides: 6 },
      { id: 3, title: "La rivelazione della CTT", subtitle: "Statins for 170,000", slides: 6 },
      { id: 4, title: "When to Pursue IPD", subtitle: "L'albero decisionale", slides: 6 },
      { id: 5, title: "One-Stage vs Two-Stage", subtitle: "Analysis approaches", slides: 6 },
      { id: 6, title: "La scoperta del timing", subtitle: "Corticosteroids & preterm birth", slides: 6 },
      { id: 7, title: "Obtaining IPD", subtitle: "La ricerca dei dati", slides: 6 },
      { id: 8, title: "Data Harmonization", subtitle: "Speaking one language", slides: 6 },
      { id: 9, title: "Testing Interactions", subtitle: "Who benefits most?", slides: 6 },
      { id: 10, title: "Prognosis & Prediction", subtitle: "IMPATTO e oltre", slides: 6 },
      { id: 11, title: "Il paradosso dell'aspirina", subtitle: "ATT: Risk determines benefit", slides: 8 },
      { id: 12, title: "The BP Revelation", subtitle: "BPLTTC: l'et√† non √® una barriera", slides: 8 },
      { id: 13, title: "La finestra del tratto", subtitle: "Time is brain", slides: 8 },
      { id: 14, title: "Missing Data", subtitle: "Le celle vuote", slides: 8 },
      { id: 15, title: "La disponibilit√† Trappola", subtitle: "Who refused to share?", slides: 8 },
      { id: 16, title: "Quiz & Sources", subtitle: "Metti alla prova le tue conoscenze", slides: 6 }
    ];

    // State management with localStorage persistence
    const STORAGE_KEY = 'ipd-course-progress';

    function loadProgress() {
      try {
        const saved = localStorage.getItem(STORAGE_KEY);
        if (saved) {
          const data = JSON.parse(saved);
          return {
            currentModule: Math.min(Math.max(1, data.currentModule || 1), modules.length),
            currentSlide: Math.max(1, data.currentSlide || 1),
            completedModules: new Set(data.completedModules || [])
          };
        }
      } catch (e) {
        console.warn('Could not load progress:', e);
      }
      return { currentModule: 1, currentSlide: 1, completedModules: new Set() };
    }

    function saveProgress() {
      try {
        const data = {
          currentModule,
          currentSlide,
          completedModules: Array.from(completedModules)
        };
        localStorage.setItem(STORAGE_KEY, JSON.stringify(data));
      } catch (e) {
        console.warn('Could not save progress:', e);
      }
    }

    // Initialize state from localStorage or defaults
    const savedState = loadProgress();
    let currentModule = savedState.currentModule;
    let currentSlide = savedState.currentSlide;
    const completedModules = savedState.completedModules;

    // Branching scenarios
    const scenarios = {
      'ipd-decision': {
        correct: 'b',
        consequences: {
          'a': { type: 'bad', text: 'Scorciatoia pericolosa! Il gruppo di lavoro REACT dell‚ÄôOMS ha studiato l‚ÄôIPD per gli steroidi COVID e ha scoperto interazioni cruciali: il beneficio era pi√π chiaro nei pazienti che necessitavano di ossigeno. L\'analisi aggregata non avrebbe colto questa sfumatura che ha plasmato la pratica clinica.', lesson: 'Quando la domanda √® "chi ne trae beneficio", l\'IPD non √® facoltativo.' },
          'b': { type: 'good', text: 'Esatto! La tua domanda sulla modifica degli effetti in base alla gravit√† e ai tempi richiede dati a livello di paziente. L\'analisi IPD del REACT Group ha mostrato che il beneficio del desametasone era concentrato nei pazienti che assumevano ossigeno, guidando il trattamento mirato.' , lesson: 'IPD is essential when testing treatment-covariate interactions.' },
          'c': { type: 'neutral', text: 'Allettante ma imperfetto. Le categorie a livello di prova differiscono: il "grave" della prova A pu√≤ essere il "moderato" della prova B. Confronteresti mele e arance. Solo l\'IPD consente di applicare definizioni di gravit√† coerenti a tutti i pazienti.', lesson: 'L\'analisi aggregata dei sottogruppi soffre dell\'errore ecologico.' }
        }
      },
      'harmonization': {
        correct: 'c',
        consequences: {
          'a': { type: 'bad', text: 'Rischioso! Le diverse definizioni di risultato potrebbero spiegare gli effetti pi√π ampi in questi studi (le definizioni pi√π vaghe catturano pi√π eventi). Includerli senza conferma potrebbe gonfiare la stima complessiva.', lesson: 'Definition heterogeneity is a form of bias. Acknowledge it.' },
          'b': { type: 'neutral', text: 'Conservativo ma potrebbe perdere informazioni preziose. Gli studi degli anni ‚Äô90 potrebbero avere popolazioni diverse che vale la pena studiare. L\'esclusione completa dovrebbe essere giustificata e non riflessiva.', lesson: 'L\'esclusione √® una decisione con conseguenze. Documenta il tuo ragionamento.' },
          'c': { type: 'good', text: 'Esatto! Questo approccio fornisce una stima primaria pulita esplorando la robustezza. Se i risultati cambiano sostanzialmente con gli studi non standardizzati, questa √® un\'informazione importante sulla sensibilit√† alla definizione del risultato.', lesson: 'Sensitivity analyses reveal what depends on your assumptions.' }
        }
      },
      'interaction': {
        correct: 'c',
        consequences: {
          'a': { type: 'bad', text: 'Overinterpretation! With 8 tests at alpha=0.05, you expect ~0.4 false positives by chance. A single p=0.03 after multiple testing is not compelling evidence of true effect modification.', lesson: 'Multiple testing inflates false positive risk. Adjust or acknowledge.' },
          'b': { type: 'neutral', text: 'Statistically appropriate (Bonferroni: 0.05/8 = 0.006 threshold) but perhaps too rigid. Biological plausibility matters too - older patients have higher stroke risk, so larger relative benefit is mechanistically sensible.', lesson: 'Statistics and biology should inform each other.' },
          'c': { type: 'good', text: 'Esatto! L‚Äôapproccio scientifico √® un reporting trasparente della natura esplorativa, il riconoscimento di molteplici test e la richiesta di convalida esterna. La scoperta √® interessante ma non definitiva.', lesson: 'Subgroup findings require replication before changing practice.' }
        }
      },
      'aspirin': {
        correct: 'b',
        consequences: {
          'a': { type: 'bad', text: 'Semplificazione eccessiva pericolosa! L‚Äôanalisi ATT IPD di 95.000 pazienti ha mostrato che negli individui a basso rischio (come questo paziente con un rischio a 10 anni dell‚Äô8%) il danno emorragico √® all‚Äôincirca uguale al beneficio cardiovascolare. Lo esporresti al rischio di emorragia per un beneficio netto trascurabile.', lesson: 'Average benefit masks risk-stratified truth. Not everyone benefits equally.' },
          'b': { type: 'good', text: 'Esatto! L\'ATT IPD-MA ha dimostrato che il rapporto beneficio-danno dell\'aspirina dipende dal rischio CVD di base. Con un rischio a 10 anni dell‚Äô8%, il numero necessario da trattare e il numero necessario per nuocere sono simili. Le attuali linee guida (AHA 2019) sconsigliano l\'uso dell\'aspirina di routine nella prevenzione primaria a basso rischio.', lesson: 'IPD ha rivelato l\'interazione rischio-beneficio che aggrega l\'id.' },
          'c': { type: 'bad', text: 'La dose non cambia il problema fondamentale. L‚Äôaspirina a basso dosaggio aumenta ancora il sanguinamento. L‚ÄôATT ha dimostrato che il rapporto beneficio-danno dipende dal rischio di base, non dalla dose. A basso rischio di malattie cardiovascolari, anche l\'aspirina per bambini causa pi√π danni che benefici.', lesson: 'Changing the dose doesn\'t fix an indication problem.' }
        }
      },
      'elderly-bp': {
        correct: 'b',
        consequences: {
          'a': { type: 'bad', text: 'Il mito della curva J √® stato sfatato dalle prove dell\'IPD. La meta-analisi BPLTTC di 344.716 pazienti ha mostrato che il beneficio proporzionale dell‚Äôabbassamento della pressione arteriosa viene mantenuto anche nei pazienti di et√† ‚â• 85 anni. Il nichilismo del trattamento basato sull‚Äôet√† nega una prevenzione efficace a coloro che potrebbero trarne maggior beneficio (rischio assoluto pi√π elevato).', lesson: 'La curva J nei dati osservazionali era una causa inversa, non un danno da trattamento.' },
          'b': { type: 'good', text: 'Correct! The BPLTTC IPD-MA found no interaction between age and treatment benefit (p=0.85). A fit 82-year-old with elevated BP stands to gain from treatment. Consider frailty and life expectancy, but not age alone.', lesson: 'L‚ÄôIPD degli RCT prevale sulle associazioni ecologiche degli studi osservazionali.' },
          'c': { type: 'bad', text: 'Aspettare un ictus o un infarto prima del trattamento vanifica lo scopo della prevenzione. Il BPLTTC ha dimostrato che la prevenzione primaria funziona a tutte le et√†. La vigile attesa in un paziente con indicazioni chiare √® dannosa.', lesson: 'Prevenire significa trattare prima dell\'evento, non dopo.' }
        }
      },
      'stroke': {
        correct: 'b',
        consequences: {
          'a': { type: 'bad', text: 'Outdated thinking! The STT IPD analysis showed benefit extends to 4.5 hours, and the 2018 guidelines expanded the window. The 3-hour cutoff was from earlier, smaller trials. Every minute counts, but 4 hours is not too late.', lesson: 'IPD allowed continuous modeling of time-benefit relationship.' },
          'b': { type: 'good', text: 'Esatto! L‚ÄôIPD-MA STT ha dimostrato che il beneficio della trombolisi, sebbene diminuito, persiste fino a 4,5 ore. A 4-4,5 ore, l\'OR per un buon risultato √® ancora ~1,26. Procedere con urgenza: ogni minuto di ulteriore ritardo riduce i benefici.', lesson: 'IPD ha rivelato la curva di decadimento che le finestre di prova distinte oscuravano.' },
          'c': { type: 'bad', text: 'Dangerous delay! MRI takes time you don\'t have. The STT showed benefit declines continuously with time. At 4 hours, you\'re already in the diminishing returns zone. Standard CT to rule out hemorrhage is sufficient; adding MRI delays treatment when every minute costs neurons.', lesson: 'Perfect is the enemy of good when time is brain.' }
        }
      },
      'missing': {
        correct: 'b',
        consequences: {
          'a': { type: 'bad', text: 'Imputazione rischiosa! Non √® possibile attribuire in modo affidabile un biomarcatore che non √® mai stato misurato in base ad altre caratteristiche. Si tratta di dati "sistematicamente mancanti": l\'imputazione sarebbe una speculazione travestita da analisi. Il meccanismo delle mancanze √® MNAR (le prove che non l\'hanno misurato potrebbero aver avuto dei motivi).', lesson: 'Non √® possibile imputare ci√≤ che non √® mai stato raccolto. Questa √® invenzione, non imputazione.' },
          'b': { type: 'good', text: 'Correct! Interaction analysis should be restricted to trials with the data. For the overall effect, you can include all trials (two-stage: IPD from 5 trials + AD from 3 trials). This maximizes appropriate use of available data while maintaining validity for each analysis type.', lesson: 'Domande diverse possono utilizzare diversi sottoinsiemi di dati.' },
          'c': { type: 'neutral', text: 'Troppo aggressivo! Questi 3 studi forniscono informazioni valide sull\'effetto complessivo del trattamento, anche se non possono fornire informazioni sull\'interazione dei biomarcatori. Escluderli completamente spreca prove e pu√≤ introdurre errori di selezione se differiscono sistematicamente.', lesson: 'Exclusion should be proportionate to the problem.' }
        }
      },
      'availability': {
        correct: 'b',
        consequences: {
          'a': { type: 'bad', text: 'Avviso errori di disponibilit√†! Gli studi di non condivisione mostrano effetti sostanzialmente minori (OR 0,95 vs 0,70). Riportare solo i risultati dell‚ÄôIPD senza riconoscere questa discrepanza sovrastimerebbe l‚Äôeffetto del trattamento. Le prove di settore spesso non condividono dati negativi.', lesson: 'Available IPD may be a biased sample of all evidence.' },
          'b': { type: 'good', text: 'Correct! Transparent reporting includes: (1) IPD retrieval rate, (2) comparison of IPD vs non-IPD trial characteristics and effects, (3) sensitivity analysis combining IPD + AD. This lets readers judge the impact of availability bias.', lesson: 'IPD quality cannot compensate for selection bias in which trials share.' },
          'c': { type: 'neutral', text: '100% IPD √® l\'ideale ma raramente raggiungibile. Aspettare indefinitamente significa che le prove non verranno mai sintetizzate. Meglio procedere con opportune avvertenze e analisi di sensibilit√† piuttosto che lasciare che la perfezione sia nemica del bene.', lesson: 'Some IPD with caveats beats no synthesis at all.' }
        }
      }
    };

    let scenarioState = {};

    function selectScenarioChoice(scenarioId, choice) {
      if (scenarioState[scenarioId]) return;

      scenarioState[scenarioId] = choice;
      const scenario = scenarios[scenarioId];
      const consequence = scenario.consequences[choice];
      const isCorrect = choice === scenario.correct;

      // Update choice styling
      const panel = document.getElementById(`scenario-${scenarioId}`);
      const choices = panel.querySelectorAll('.scenario-choice');
      choices.forEach(c => {
        c.classList.add('answered');
        const letter = c.querySelector('.choice-letter').textContent.toLowerCase();
        if (letter === scenario.correct) c.classList.add('correct');
        if (letter === choice && !isCorrect) c.classList.add('incorrect');
      });

      // Show consequence
      const conseqDiv = document.getElementById(`consequence-${scenarioId}`);
      conseqDiv.innerHTML = `
        <div class="consequence-title">${isCorrect ? '&#10003; Good decision!' : '&#10007; Problematic decision'}</div>
        <div class="consequence-text">${consequence.text}</div>
        <div class="consequence-lesson">"${consequence.lesson}"</div>
      `;
      conseqDiv.classList.add('visible', consequence.type);
    }

    function init() {
      // Restore saved progress - activate correct module and slide
      if (currentModule > 1 || currentSlide > 1) {
        // Deactivate default first module
        document.querySelectorAll('.module-slides').forEach(el => el.classList.remove('active'));
        document.querySelectorAll('.slide').forEach(el => el.classList.remove('active'));

        // Activate saved module
        const targetModuleEl = document.querySelector(`.module-slides[data-module="${currentModule}"]`);
        if (targetModuleEl) {
          targetModuleEl.classList.add('active');

          // Activate saved slide within module
          const slides = targetModuleEl.querySelectorAll('.slide');
          const targetSlideIndex = Math.min(currentSlide - 1, slides.length - 1);
          if (slides[targetSlideIndex]) {
            slides[targetSlideIndex].classList.add('active');
          }
        }

        // Update breadcrumb
        const moduleTitle = modules[currentModule - 1];
        if (moduleTitle) {
          document.getElementById('currentModule').textContent = moduleTitle.title;
        }

        // Progress restored: Module ${currentModule}, Slide ${currentSlide}
      }

      renderModuleList();
      updateSlideNav();

      // Keyboard navigation
      document.addEventListener('keydown', (e) => {
        // Don't intercept if user is in an input/interactive field
        if (e.target.tagName === 'INPUT' || e.target.tagName === 'TEXTAREA' ||
            e.target.tagName === 'SELECT' || e.target.tagName === 'BUTTON' ||
            e.target.tagName === 'A' ||
            (e.target.getAttribute && e.target.getAttribute('role') === 'button')) return;

        if (e.key === 'ArrowRight' || e.key === ' ') {
          e.preventDefault();
          nextSlide();
        } else if (e.key === 'ArrowLeft') {
          e.preventDefault();
          prevSlide();
        } else if (e.key === 'Home') {
          e.preventDefault();
          goToModule(1);
        } else if (e.key === 'End') {
          e.preventDefault();
          goToModule(modules.length);
        }
      });

      // Touch swipe support for mobile
      let touchStartX = 0;
      let touchEndX = 0;
      const slidesContainer = document.getElementById('main-content');

      if (slidesContainer) {
        slidesContainer.addEventListener('touchstart', (e) => {
          touchStartX = e.changedTouches[0].screenX;
        }, { passive: true });

        slidesContainer.addEventListener('touchend', (e) => {
          touchEndX = e.changedTouches[0].screenX;
          handleSwipe();
        }, { passive: true });
      }

      function handleSwipe() {
        const swipeThreshold = 50;
        const diff = touchStartX - touchEndX;
        if (Math.abs(diff) > swipeThreshold) {
          if (diff > 0) {
            nextSlide(); // Swipe left = next
          } else {
            prevSlide(); // Swipe right = prev
          }
        }
      }

      // Save progress before user leaves
      window.addEventListener('beforeunload', saveProgress);

      // Announce initial slide to screen readers
      announceSlide();

      // Show initial progress percentage
      updateProgressPercent();
    }

    // Accessibility: Announce slide changes to screen readers
    function announceSlide() {
      const module = modules[currentModule - 1];
      if (!module) return;

      const announcement = `Module ${currentModule}: ${module.title}. Slide ${currentSlide} of ${module.slides}.`;
      const liveRegion = document.getElementById('ariaLiveRegion');
      if (liveRegion) {
        liveRegion.textContent = announcement;
      }

      updateProgressPercent();
    }

    // Update completion percentage display
    function updateProgressPercent() {
      const totalSlides = modules.reduce((sum, m) => sum + m.slides, 0);
      let completedSlides = 0;

      // Count slides in completed modules
      completedModules.forEach(moduleId => {
        const mod = modules.find(m => m.id === moduleId);
        if (mod) completedSlides += mod.slides;
      });

      // Add current progress in current module
      completedSlides += currentSlide - 1;

      const percent = Math.round((completedSlides / totalSlides) * 100);
      const progressEl = document.getElementById('progressPercent');
      if (progressEl) {
        progressEl.textContent = `Progress: ${percent}%`;
      }
    }

    function renderModuleList() {
      const list = document.getElementById('moduleList');
      list.innerHTML = modules.map(m => `
        <div class="module-item ${m.id === currentModule ? 'active' : ''} ${completedModules.has(m.id) ? 'completed' : ''}"
             onclick="goToModule(${m.id})"
             onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();event.stopPropagation();goToModule(${m.id});}"
             role="listitem"
             tabindex="0"
             aria-label="Module ${m.id}: ${m.title}. ${m.subtitle}. ${completedModules.has(m.id) ? 'Completed.' : ''} ${m.id === currentModule ? 'Current module.' : ''}"
             aria-current="${m.id === currentModule ? 'true' : 'false'}">
          <div class="module-number" aria-hidden="true">${completedModules.has(m.id) ? '&#10003;' : m.id}</div>
          <div class="module-info">
            <div class="module-title">${m.title}</div>
            <div class="module-subtitle">${m.subtitle}</div>
          </div>
        </div>
      `).join('');
    }

    function goToModule(moduleId) {
      // Bounds checking
      if (moduleId < 1 || moduleId > modules.length) {
        console.warn(`Invalid module ID: ${moduleId}. Must be between 1 and ${modules.length}.`);
        return;
      }

      if (moduleId > currentModule) completedModules.add(currentModule);
      currentModule = moduleId;

      // Ensure slide is within bounds for new module
      const targetModule = modules[moduleId - 1];
      currentSlide = Math.min(Math.max(1, currentSlide), targetModule.slides);
      currentSlide = 1; // Start at first slide of new module

      document.querySelectorAll('.module-slides').forEach(el => el.classList.remove('active'));
      const targetModuleEl = document.querySelector(`.module-slides[data-module="${moduleId}"]`);
      if (targetModuleEl) {
        targetModuleEl.classList.add('active');
      }

      updateSlideVisibility();
      updateSlideNav();
      renderModuleList();

      const moduleTitle = modules[moduleId - 1];
      if (moduleTitle) {
        document.getElementById('currentModule').textContent = moduleTitle.title;
      }

      saveProgress();
      announceSlide();
    }

    function updateSlideVisibility() {
      const moduleSlides = document.querySelector(`.module-slides[data-module="${currentModule}"]`);
      if (!moduleSlides) {
        console.warn(`Module slides not found for module ${currentModule}`);
        return;
      }
      const slides = moduleSlides.querySelectorAll('.slide');
      slides.forEach((slide, index) => slide.classList.toggle('active', index + 1 === currentSlide));
    }

    function updateSlideNav() {
      const module = modules[currentModule - 1];
      if (!module) {
        console.warn(`Module data not found for index ${currentModule - 1}`);
        return;
      }
      const slideCounter = document.getElementById('slideCounter');
      const progressDots = document.getElementById('progressDots');
      if (slideCounter) {
        slideCounter.textContent = `${currentSlide} / ${module.slides}`;
      }
      if (progressDots) {
        progressDots.innerHTML = Array.from({ length: module.slides }, (_, i) =>
          `<div class="progress-dot ${i + 1 === currentSlide ? 'active' : ''}"
                onclick="goToSlide(${i + 1})"
                onkeydown="if(event.key==='Enter'||event.key===' '){event.preventDefault();event.stopPropagation();goToSlide(${i + 1});}"
                role="tab"
                tabindex="${i + 1 === currentSlide ? '0' : '-1'}"
                aria-selected="${i + 1 === currentSlide ? 'true' : 'false'}"
                aria-label="Go to slide ${i + 1}"></div>`
        ).join('');
      }
    }

    // Reset progress function (can be called from console or UI)
    function resetProgress() {
      try {
        localStorage.removeItem(STORAGE_KEY);
        currentModule = 1;
        currentSlide = 1;
        completedModules.clear();

        // Reset UI
        document.querySelectorAll('.module-slides').forEach(el => el.classList.remove('active'));
        document.querySelectorAll('.slide').forEach(el => el.classList.remove('active'));

        const firstModule = document.querySelector('.module-slides[data-module="1"]');
        if (firstModule) {
          firstModule.classList.add('active');
          const firstSlide = firstModule.querySelector('.slide');
          if (firstSlide) firstSlide.classList.add('active');
        }

        document.getElementById('currentModule').textContent = modules[0].title;
        renderModuleList();
        updateSlideNav();
        updateProgressPercent();
        announceSlide();

        // Progress reset successfully
      } catch (e) {
        console.error('Failed to reset progress:', e);
      }
    }

    function goToSlide(slideNum) {
      // Bounds checking
      const module = modules[currentModule - 1];
      if (!module || slideNum < 1 || slideNum > module.slides) {
        console.warn(`Invalid slide number: ${slideNum}. Must be between 1 and ${module ? module.slides : '?'}.`);
        return;
      }

      currentSlide = slideNum;
      updateSlideVisibility();
      updateSlideNav();
      saveProgress();
      announceSlide();
    }

    function nextSlide() {
      // Bounds checking
      if (currentModule < 1 || currentModule > modules.length) {
        console.warn('Invalid current module state');
        currentModule = 1;
        currentSlide = 1;
        saveProgress();
        return;
      }

      const module = modules[currentModule - 1];
      if (!module) return;

      if (currentSlide < module.slides) {
        currentSlide++;
        updateSlideVisibility();
        updateSlideNav();
        saveProgress();
        announceSlide();
      } else if (currentModule < modules.length) {
        goToModule(currentModule + 1);
      }
      // If at last slide of last module, do nothing (already handled)
    }

    function prevSlide() {
      // Bounds checking
      if (currentModule < 1 || currentModule > modules.length) {
        console.warn('Invalid current module state');
        currentModule = 1;
        currentSlide = 1;
        saveProgress();
        return;
      }

      if (currentSlide > 1) {
        currentSlide--;
        updateSlideVisibility();
        updateSlideNav();
        saveProgress();
        announceSlide();
      } else if (currentModule > 1) {
        // Bounds check for previous module
        const prevModuleIndex = currentModule - 2;
        if (prevModuleIndex < 0 || prevModuleIndex >= modules.length) {
          console.warn('Invalid previous module index');
          return;
        }

        const prevModuleSlides = modules[prevModuleIndex].slides;
        currentModule--;
        currentSlide = prevModuleSlides;

        document.querySelectorAll('.module-slides').forEach(el => el.classList.remove('active'));
        const targetModuleEl = document.querySelector(`.module-slides[data-module="${currentModule}"]`);
        if (targetModuleEl) {
          targetModuleEl.classList.add('active');
        }

        updateSlideVisibility();
        updateSlideNav();
        renderModuleList();

        const moduleTitle = modules[currentModule - 1];
        if (moduleTitle) {
          document.getElementById('currentModule').textContent = moduleTitle.title;
        }

        saveProgress();
        announceSlide();
      }
      // If at first slide of first module, do nothing (already handled)
    }

    function checkAnswer(element, isCorrect) {
      const container = element.closest('.quiz-container');
      const options = container.querySelectorAll('.quiz-option');
      const feedback = container.querySelector('.quiz-feedback');

      options.forEach(opt => {
        opt.style.pointerEvents = 'none';
        if (opt === element) opt.classList.add(isCorrect ? 'correct' : 'incorrect');
      });

      feedback.classList.add('show', isCorrect ? 'correct' : 'incorrect');
      feedback.innerHTML = isCorrect
        ? '<strong>Correct!</strong> You understand the key concept.'
        : '<strong>Not quite.</strong> Review the module to understand why.';
    }

    // ==================== THEME TOGGLE ====================
    function toggleTheme() {
      const body = document.body;
      const themeBtn = document.getElementById('themeToggle');
      const isLight = body.classList.toggle('light-theme');

      // Update button icon
      if (themeBtn) {
        themeBtn.textContent = isLight ? 'üåô' : '‚òÄÔ∏è';
        themeBtn.setAttribute('aria-label', isLight ? 'Switch to dark mode' : 'Switch to light mode');
      }

      // Save preference
      try {
        localStorage.setItem('ipd-course-theme', isLight ? 'light' : 'dark');
      } catch (e) {
        console.warn('Could not save theme preference');
      }
    }

    function loadTheme() {
      try {
        const savedTheme = localStorage.getItem('ipd-course-theme');
        const themeBtn = document.getElementById('themeToggle');

        if (savedTheme === 'light') {
          document.body.classList.add('light-theme');
          if (themeBtn) {
            themeBtn.textContent = 'üåô';
            themeBtn.setAttribute('aria-label', 'Switch to dark mode');
          }
        }
      } catch (e) {
        console.warn('Could not load theme preference');
      }
    }

    // ==================== CERTIFICATE ====================
    function showCertificate() {
      const modal = document.getElementById('certificateModal');
      const dateEl = document.getElementById('certDate');

      if (modal) {
        modal.classList.add('visible');

        // Set current date
        if (dateEl) {
          const now = new Date();
          const options = { year: 'numeric', month: 'long', day: 'numeric' };
          dateEl.textContent = `Completed on ${now.toLocaleDateString('en-US', options)}`;
        }

        // Focus the name input
        const nameInput = document.getElementById('certName');
        if (nameInput) {
          setTimeout(() => nameInput.focus(), 100);
        }
      }
    }

    function closeCertificate() {
      const modal = document.getElementById('certificateModal');
      if (modal) {
        modal.classList.remove('visible');
      }
    }

    function printCertificate() {
      const name = document.getElementById('certName')?.value || 'Course Participant';
      const certContent = document.getElementById('certificateContent');

      if (!certContent) return;

      // Temporarily replace input with name text
      const nameInput = document.getElementById('certName');
      const originalHTML = nameInput?.outerHTML;
      if (nameInput) {
        const nameSpan = document.createElement('span');
        nameSpan.className = 'certificate-name';
        nameSpan.textContent = name;
        nameInput.replaceWith(nameSpan);
      }

      // Hide action buttons for print
      const actions = certContent.querySelector('.certificate-actions');
      const closeBtn = certContent.querySelector('.certificate-close');
      if (actions) actions.style.display = 'none';
      if (closeBtn) closeBtn.style.display = 'none';

      // Print
      const printWindow = window.open('', '_blank');
      printWindow.document.write(`
        <!DOCTYPE html>
        <html>
        <head>
          <title>Certificate - IPD Meta-Analysis Course</title>
          <link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&display=swap" rel="stylesheet">
          <style>
            body { margin: 0; padding: 2rem; font-family: 'Cormorant Garamond', Georgia, serif; }
            .certificate {
              background: linear-gradient(135deg, #faf8f5 0%, #fff 100%);
              border: 8px solid #D4AF37;
              border-radius: 12px;
              padding: 3rem;
              max-width: 700px;
              margin: 0 auto;
              text-align: center;
            }
            .certificate-header { font-size: 2.5rem; color: #1E2761; margin-bottom: 0.5rem; }
            .certificate-subtitle { font-size: 1rem; color: #718096; margin-bottom: 2rem; letter-spacing: 0.2em; text-transform: uppercase; }
            .certificate-body { font-size: 1.2rem; color: #2D3748; line-height: 1.8; margin-bottom: 2rem; }
            .certificate-name { font-size: 2rem; font-weight: 700; color: #1E2761; border-bottom: 2px solid #D4AF37; display: inline-block; padding: 0 2rem 0.5rem; margin: 1rem 0; }
            .certificate-date { font-size: 0.9rem; color: #718096; margin-top: 1.5rem; }
            .certificate-seal { width: 80px; height: 80px; background: linear-gradient(135deg, #D4AF37, #B8860B); border-radius: 50%; display: flex; align-items: center; justify-content: center; margin: 1.5rem auto 0; color: white; font-size: 2rem; }
          </style>
        </head>
        <body>
          ${certContent.innerHTML}
        </body>
        </html>
      `);
      printWindow.document.close();
      printWindow.print();

      // Restore original state
      if (actions) actions.style.display = '';
      if (closeBtn) closeBtn.style.display = '';
      const nameSpan = certContent.querySelector('.certificate-name');
      if (nameSpan && originalHTML) {
        nameSpan.outerHTML = originalHTML;
      }
    }

    function downloadCertificate() {
      const name = document.getElementById('certName')?.value || 'Course Participant';
      const dateEl = document.getElementById('certDate')?.textContent || '';

      // Create a canvas-based certificate image
      const canvas = document.createElement('canvas');
      canvas.width = 1000;
      canvas.height = 700;
      const ctx = canvas.getContext('2d');

      // Background gradient
      const gradient = ctx.createLinearGradient(0, 0, 1000, 700);
      gradient.addColorStop(0, '#faf8f5');
      gradient.addColorStop(1, '#ffffff');
      ctx.fillStyle = gradient;
      ctx.fillRect(0, 0, 1000, 700);

      // Border
      ctx.strokeStyle = '#D4AF37';
      ctx.lineWidth = 16;
      ctx.strokeRect(20, 20, 960, 660);

      // Inner border
      ctx.strokeStyle = '#1E2761';
      ctx.lineWidth = 2;
      ctx.strokeRect(40, 40, 920, 620);

      // Header
      ctx.fillStyle = '#1E2761';
      ctx.font = 'bold 48px Georgia, serif';
      ctx.textAlign = 'center';
      ctx.fillText('Certificate of Completion', 500, 120);

      // Subtitle
      ctx.fillStyle = '#718096';
      ctx.font = '18px Arial, sans-serif';
      ctx.letterSpacing = '0.2em';
      ctx.fillText('INDIVIDUAL PARTICIPANT DATA META-ANALYSIS', 500, 160);

      // Body text
      ctx.fillStyle = '#2D3748';
      ctx.font = '22px Georgia, serif';
      ctx.fillText('This certifies that', 500, 240);

      // Name
      ctx.fillStyle = '#1E2761';
      ctx.font = 'bold 36px Georgia, serif';
      ctx.fillText(name, 500, 300);

      // Name underline
      const nameWidth = ctx.measureText(name).width;
      ctx.strokeStyle = '#D4AF37';
      ctx.lineWidth = 2;
      ctx.beginPath();
      ctx.moveTo(500 - nameWidth/2 - 20, 315);
      ctx.lineTo(500 + nameWidth/2 + 20, 315);
      ctx.stroke();

      // More body text
      ctx.fillStyle = '#2D3748';
      ctx.font = '22px Georgia, serif';
      ctx.fillText('has successfully completed the course', 500, 380);
      ctx.font = 'bold 24px Georgia, serif';
      ctx.fillText('"The Hidden Patient: IPD Meta-Analysis"', 500, 420);
      ctx.font = '18px Georgia, serif';
      ctx.fillText('demonstrating understanding of individual participant data', 500, 460);
      ctx.fillText('synthesis methods and their clinical applications.', 500, 485);

      // Date
      ctx.fillStyle = '#718096';
      ctx.font = '16px Arial, sans-serif';
      ctx.fillText(dateEl, 500, 540);

      // Seal
      ctx.fillStyle = '#D4AF37';
      ctx.beginPath();
      ctx.arc(500, 610, 40, 0, Math.PI * 2);
      ctx.fill();
      ctx.fillStyle = 'white';
      ctx.font = 'bold 36px Arial, sans-serif';
      ctx.fillText('‚úì', 500, 625);

      // Download
      const link = document.createElement('a');
      link.download = `IPD-Certificate-${name.replace(/[^a-zA-Z0-9\s-]/g, '').replace(/\s+/g, '-')}.png`;
      link.href = canvas.toDataURL('image/png');
      link.click();
    }

    // Close certificate with Escape key
    document.addEventListener('keydown', (e) => {
      if (e.key === 'Escape') {
        closeCertificate();
      }
    });

    // Close certificate when clicking outside
    document.getElementById('certificateModal')?.addEventListener('click', (e) => {
      if (e.target.id === 'certificateModal') {
        closeCertificate();
      }
    });

    // ==================== INIT ====================
    init();
    loadTheme();
  </script>
</body>
</html>
